{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:17:40Z","timestamp":1792783060221,"version":"4.5.0"},"reference-count":377,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Iran National Institute for Medical Research Development","award":["4021512"],"award-info":[{"award-number":["4021512"]}],"id":[{"id":"https:\/\/ror.org\/046k81c97","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Kermanshah University of Medical Sciences","award":["4030006"],"award-info":[{"award-number":["4030006"]}],"id":[{"id":"https:\/\/ror.org\/05vspf741","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10787-026-02364-6","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:38:01Z","timestamp":1789105081000},"page":"6605-6642","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Large-scale comparative virtual screening identifies novel molecular targets underlying the multi-target activity of quercetin in psoriasis"],"prefix":"10.1007","volume":"34","author":[{"given":"Mina","family":"Barhoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Mahdiuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Khodarahmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"2364_CR1","doi-asserted-by":"crossref","unstructured":"Abou El-Fadl, D.A.E.-G., et al., Immunohistochemical Assessment of Phosphodiesterase 4A and Phosphodiesterase 4D in Relation to Serum Levels of Phosphodiesterase 4 in Patients with Chronic Plaque Psoriasis. QJM: An International Journal of Medicine, 2024. 117(Supplement_1): p. hcae070. 168.","DOI":"10.1093\/qjmed\/hcae070.168"},{"key":"2364_CR2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ et al (2015) GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1:19\u201325","journal-title":"SoftwareX"},{"key":"2364_CR3","doi-asserted-by":"crossref","unstructured":"Aghelan, Z., et al., Comparative Investigation of Antioxidant Effects in Different Binary Systems: Does Quercetin Stabilize Ascorbic Acid\/Resveratrol in Their Binary Mixtures? Journal of Reports in Pharmaceutical Sciences, 2025. 13(13).","DOI":"10.5812\/jrps-156437"},{"key":"2364_CR4","doi-asserted-by":"crossref","unstructured":"Aguilar-Flores, C., et al., Association of pathogenic Th17 cells with the disease severity and its potential implication for biological treatment selection in psoriasis patients. Mediators of Inflammation, 2020. 2020(1): p. 8065147.","DOI":"10.1155\/2020\/8065147"},{"issue":"11","key":"2364_CR5","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0006-2952(97)82453-7","volume":"53","author":"G Agullo","year":"1997","unstructured":"Agullo G et al (1997) Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 53(11):1649\u20131657","journal-title":"Biochem Pharmacol"},{"issue":"13","key":"2364_CR6","doi-asserted-by":"crossref","first-page":"E2748","DOI":"10.1073\/pnas.1620954114","volume":"114","author":"JS Ainscough","year":"2017","unstructured":"Ainscough JS et al (2017) Cathepsin S is the major activator of the psoriasis-associated proinflammatory cytokine IL-36\u03b3. Proc Natl Acad Sci U S A 114(13):E2748\u2013E2757","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2364_CR7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/pathophysiology31030035","volume":"31","author":"TA Ajani","year":"2024","unstructured":"Ajani TA et al (2024) Advances in cathepsin S inhibition: challenges and breakthroughs in drug development. Pathophysiology 31(3):471\u2013487","journal-title":"Pathophysiology"},{"key":"2364_CR8","volume":"877","author":"NO Al-Harbi","year":"2020","unstructured":"Al-Harbi NO et al (2020) Therapeutic treatment with Ibrutinib attenuates imiquimod-induced psoriasis-like inflammation in mice through downregulation of oxidative and inflammatory mediators in neutrophils and dendritic cells. Eur J Pharmacol 877:173088","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"2364_CR9","first-page":"139","volume":"29","author":"H Ali","year":"2014","unstructured":"Ali H, Dixit S (2014) Quercetin attenuates the development of 7, 12-dimethyl benz (a) anthracene (DMBA) and croton oil-induced skin cancer in mice. J Biomed Res 29(2):139","journal-title":"J Biomed Res"},{"issue":"9","key":"2364_CR10","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.3390\/molecules27092901","volume":"27","author":"JM Al-Khayri","year":"2022","unstructured":"Al-Khayri JM et al (2022) Flavonoids as potential anti-inflammatory molecules: a review. Molecules 27(9):2901","journal-title":"Molecules"},{"issue":"15","key":"2364_CR11","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/jcc.23905","volume":"36","author":"WJ Allen","year":"2015","unstructured":"Allen WJ et al (2015) DOCK 6: impact of new features and current docking performance. J Comput Chem 36(15):1132\u20131156","journal-title":"J Comput Chem"},{"key":"2364_CR12","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.reth.2024.04.016","volume":"27","author":"Y An","year":"2024","unstructured":"An Y et al (2024) Quercetin through miR-147\u20135p\/Clip3 axis reducing Th17 cell differentiation to alleviate periodontitis. Regen Ther 27:496\u2013505","journal-title":"Regen Ther"},{"issue":"1","key":"2364_CR13","doi-asserted-by":"crossref","first-page":"1700447","DOI":"10.1002\/mnfr.201700447","volume":"62","author":"S Andres","year":"2018","unstructured":"Andres S et al (2018) Safety aspects of the use of quercetin as a dietary supplement. Mol Nutr Food Res 62(1):1700447","journal-title":"Mol Nutr Food Res"},{"key":"2364_CR14","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.126059.2","author":"P Anuranjana","year":"2023","unstructured":"Anuranjana P et al (2023) Mechanisms behind the pharmacological application of biochanin-A: a review. F1000Res. https:\/\/doi.org\/10.12688\/f1000research.126059.2","journal-title":"F1000Res"},{"issue":"9","key":"2364_CR15","first-page":"1785","volume":"10","author":"D Arsenov","year":"2021","unstructured":"Arsenov D et al (2021) Roots of Apium graveolens and Petroselinum crispum\u2014insight into phenolic status against toxicity level of trace elements. Plants (Basel) 10(9):1785","journal-title":"Plants (Basel)"},{"issue":"6","key":"2364_CR16","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.chembiol.2023.05.007","volume":"30","author":"ML Arwood","year":"2023","unstructured":"Arwood ML et al (2023) New scaffolds for type II JAK2 inhibitors overcome the acquired G993A resistance mutation. Cell Chem Biol 30(6):618-631. e12","journal-title":"Cell Chem Biol"},{"key":"2364_CR17","unstructured":"Aryani, S. and G. Gurid, The Retention of Phytoestrogens (Daidzein And Genistein) on Tofu and Tempe due to fried and boiled treatments. Sapporo Medical Journal, 2020. 57(7)."},{"issue":"9","key":"2364_CR18","doi-asserted-by":"crossref","first-page":"15842","DOI":"10.3390\/molecules200915842","volume":"20","author":"A Astolfi","year":"2015","unstructured":"Astolfi A et al (2015) P38\u03b1 MAPK and type I inhibitors: binding site analysis and use of target ensembles in virtual screening. Molecules 20(9):15842\u201315861","journal-title":"Molecules"},{"issue":"9993","key":"2364_CR19","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0140-6736(14)62113-9","volume":"386","author":"H Bachelez","year":"2015","unstructured":"Bachelez H et al (2015) Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial. Lancet 386(9993):552\u2013561","journal-title":"Lancet"},{"key":"2364_CR20","volume":"267","author":"L Bai","year":"2024","unstructured":"Bai L et al (2024) CETSA-MS-based target profiling of anti-aging natural compound quercetin. Eur J Med Chem 267:116203","journal-title":"Eur J Med Chem"},{"issue":"11","key":"2364_CR21","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.3390\/biom10111546","volume":"10","author":"A Baier","year":"2020","unstructured":"Baier A, Szyszka R (2020) Compounds from natural sources as protein kinase inhibitors. Biomolecules 10(11):1546","journal-title":"Biomolecules"},{"issue":"2","key":"2364_CR22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/1574886315666200128095958","volume":"15","author":"H Bakshi","year":"2020","unstructured":"Bakshi H et al (2020) Treatment of psoriasis: a comprehensive review of entire therapies. Curr Drug Saf 15(2):82\u2013104","journal-title":"Curr Drug Saf"},{"issue":"4","key":"2364_CR23","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s13555-020-00409-4","volume":"10","author":"DMW Balak","year":"2020","unstructured":"Balak DMW et al (2020) Long-term safety of oral systemic therapies for psoriasis: a comprehensive review of the literature. Dermatol Ther (Heidelb) 10(4):589\u2013613","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"2","key":"2364_CR24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1124\/jpet.117.242909","volume":"363","author":"T Barf","year":"2017","unstructured":"Barf T et al (2017) Acalabrutinib (ACP-196): a covalent Bruton tyrosine kinase inhibitor with a differentiated selectivity and in vivo potency profile. J Pharmacol Exp Ther 363(2):240\u2013252","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"2364_CR25","volume":"9","author":"GE-S Batiha","year":"2020","unstructured":"Batiha GE-S et al (2020) The pharmacological activity, biochemical properties, and pharmacokinetics of the major natural polyphenolic flavonoid: quercetin. Foods 9(3):374","journal-title":"Foods"},{"issue":"7","key":"2364_CR26","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.3390\/jcm13071940","volume":"13","author":"T Battista","year":"2024","unstructured":"Battista T et al (2024) Biological therapy for psoriasis in cancer patients: an 8-year retrospective real-life study. J Clin Med 13(7):1940","journal-title":"J Clin Med"},{"issue":"2","key":"2364_CR27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ptr.5978","volume":"32","author":"SK Bedada","year":"2018","unstructured":"Bedada SK, Neerati P (2018) Evaluation of the effect of quercetin treatment on CYP2C9 enzyme activity of diclofenac in healthy human volunteers. Phytother Res 32(2):305\u2013311","journal-title":"Phytother Res"},{"key":"2364_CR28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-1-4939-9752-7_10","volume-title":"Docking screens for drug discovery","author":"G Bitencourt-Ferreira","year":"2019","unstructured":"Bitencourt-Ferreira G, d. Azevedo WF (2019) Molegro virtual docker for docking. Docking screens for drug discovery. Springer, pp 149\u2013167"},{"issue":"1","key":"2364_CR29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/molecules28010175","volume":"28","author":"C Blanes-Mira","year":"2022","unstructured":"Blanes-Mira C et al (2022) Comprehensive survey of consensus docking for high-throughput virtual screening. Molecules 28(1):175","journal-title":"Molecules"},{"issue":"12","key":"2364_CR30","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1007\/s13555-023-01054-3","volume":"13","author":"A Blauvelt","year":"2023","unstructured":"Blauvelt A et al (2023) Next generation PDE4 inhibitors that selectively target PDE4B\/D subtypes: a narrative review. Dermatol Ther 13(12):3031\u20133042","journal-title":"Dermatol Ther"},{"key":"2364_CR31","volume":"16","author":"Y Bo","year":"2025","unstructured":"Bo Y, Li Y (2025) Multi-target mechanisms and potential applications of quercetin in the treatment of acne vulgaris. Front Pharmacol 16:1523905","journal-title":"Front Pharmacol"},{"issue":"1","key":"2364_CR32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1523-1747.2002.01800.x","volume":"119","author":"W-H Boehncke","year":"2002","unstructured":"Boehncke W-H et al (2002) Cathepsin S activity is detectable in human keratinocytes and is selectively upregulated upon stimulation with interferon-\u03b3. J Invest Dermatol 119(1):44\u201349","journal-title":"J Invest Dermatol"},{"issue":"3","key":"2364_CR33","first-page":"833","volume":"38","author":"R Boly","year":"2011","unstructured":"Boly R et al (2011) Quercetin inhibits a large panel of kinases implicated in cancer cell biology. Int J Oncol 38(3):833\u2013842","journal-title":"Int J Oncol"},{"key":"2364_CR34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/B978-0-12-805417-8.00023-8","volume-title":"Immunity and inflammation in health and disease","author":"M Bonesi","year":"2018","unstructured":"Bonesi M et al (2018) Flavonoids in treating psoriasis. Immunity and inflammation in health and disease. Elsevier, pp 281\u2013294"},{"issue":"3","key":"2364_CR35","first-page":"297","volume":"13","author":"AD Boran","year":"2010","unstructured":"Boran AD, Iyengar R (2010) Systems approaches to polypharmacology and drug discovery. Curr Opin Drug Discov Devel 13(3):297\u2013309","journal-title":"Curr Opin Drug Discov Devel"},{"issue":"9","key":"2364_CR36","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1038\/jid.2011.139","volume":"131","author":"HJ Bovenschen","year":"2011","unstructured":"Bovenschen HJ et al (2011) Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. J Invest Dermatol 131(9):1853\u20131860","journal-title":"J Invest Dermatol"},{"key":"2364_CR37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1186455","volume":"14","author":"NC Brembilla","year":"2023","unstructured":"Brembilla NC, Boehncke W-H (2023) Revisiting the interleukin 17 family of cytokines in psoriasis: pathogenesis and potential targets for innovative therapies. Front Immunol 14:1186455","journal-title":"Front Immunol"},{"key":"2364_CR38","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3389\/fimmu.2015.00530","volume":"6","author":"V Brezar","year":"2015","unstructured":"Brezar V, Tu WJ, Seddiki N (2015) PKC-theta in regulatory and effector T-cell functions. Front Immunol 6:530","journal-title":"Front Immunol"},{"issue":"14","key":"2364_CR39","doi-asserted-by":"crossref","first-page":"7641","DOI":"10.3390\/ijms22147641","volume":"22","author":"C Brullo","year":"2021","unstructured":"Brullo C et al (2021) Btk inhibitors: a medicinal chemistry and drug delivery perspective. Int J Mol Sci 22(14):7641","journal-title":"Int J Mol Sci"},{"key":"2364_CR40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.621956","volume":"12","author":"H Bugaut","year":"2021","unstructured":"Bugaut H, Aractingi S (2021) Major role of the IL17\/23 axis in psoriasis supports the development of new targeted therapies. Front Immunol 12:621956","journal-title":"Front Immunol"},{"issue":"21","key":"2364_CR41","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1021\/acs.jcim.3c01053","volume":"63","author":"M Bugnon","year":"2023","unstructured":"Bugnon M et al (2023) SwissParam 2023: a modern web-based tool for efficient small molecule parametrization. J Chem Inf Model 63(21):6469\u20136475","journal-title":"J Chem Inf Model"},{"issue":"1","key":"2364_CR42","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00394-015-1084-x","volume":"56","author":"C Burak","year":"2017","unstructured":"Burak C et al (2017) Higher plasma quercetin levels following oral administration of an onion skin extract compared with pure quercetin dihydrate in humans. Eur J Nutr 56(1):343\u2013353","journal-title":"Eur J Nutr"},{"issue":"4","key":"2364_CR43","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/cmi.2012.15","volume":"9","author":"Y Cai","year":"2012","unstructured":"Cai Y, Fleming C, Yan J (2012) New insights of T cells in the pathogenesis of psoriasis. Cell Mol Immunol 9(4):302\u2013309","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"2364_CR44","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3390\/antiox10020328","volume":"10","author":"R Cannataro","year":"2021","unstructured":"Cannataro R et al (2021) Polyphenols in the Mediterranean diet: from dietary sources to microRNA modulation. Antioxidants (Basel) 10(2):328","journal-title":"Antioxidants (Basel)"},{"issue":"7","key":"2364_CR45","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1021\/np500320g","volume":"77","author":"H Cao","year":"2014","unstructured":"Cao H, Pauff JM, Hille R (2014) X-ray crystal structure of a xanthine oxidase complex with the flavonoid inhibitor quercetin. J Nat Prod 77(7):1693\u20131699","journal-title":"J Nat Prod"},{"issue":"9","key":"2364_CR46","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1021\/acs.jafc.4c06704","volume":"73","author":"Z Cao","year":"2025","unstructured":"Cao Z et al (2025) Luteolin mitigates acute lung injury through immune modulation and antinecroptosis effects by targeting the BTK and FLT3 signaling pathways. J Agric Food Chem 73(9):5180\u20135193","journal-title":"J Agric Food Chem"},{"issue":"11","key":"2364_CR47","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/jdv.12549","volume":"28","author":"JM Carrascosa","year":"2014","unstructured":"Carrascosa JM et al (2014) Clinical relevance of immunogenicity of biologics in psoriasis: implications for treatment strategies. J Eur Acad Dermatol Venereol 28(11):1424\u20131430","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"2364_CR48","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3390\/molecules29051000","volume":"29","author":"EJ Carrillo-Martinez","year":"2024","unstructured":"Carrillo-Martinez EJ et al (2024) Quercetin, a flavonoid with great pharmacological capacity. Molecules 29(5):1000","journal-title":"Molecules"},{"issue":"Pt 11","key":"2364_CR49","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1107\/S2053230X16016356","volume":"72","author":"NL Caspers","year":"2016","unstructured":"Caspers NL et al (2016) Development of a high-throughput crystal structure-determination platform for JAK1 using a novel metal-chelator soaking system. Acta Crystallogr F Struct Biol Commun 72(Pt 11):840\u2013845","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"issue":"6","key":"2364_CR50","first-page":"854","volume":"96","author":"JC Chamcheu","year":"2016","unstructured":"Chamcheu JC et al (2016) Upregulation of PI3K\/AKT\/mTOR, FABP5 and PPAR\u03b2\/\u03b4 in human psoriasis and imiquimod-induced murine psoriasiform dermatitis model. Acta Derm Venereol 96(6):854","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"2364_CR51","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/2040622318759282","volume":"9","author":"TC Chan","year":"2018","unstructured":"Chan TC, Hawkes JE, Krueger JG (2018) Interleukin 23 in the skin: role in psoriasis pathogenesis and selective interleukin 23 blockade as treatment. Ther Adv Chronic Dis 9(5):111\u2013119","journal-title":"Ther Adv Chronic Dis"},{"issue":"11","key":"2364_CR52","volume":"7","author":"S-F Chen","year":"2012","unstructured":"Chen S-F et al (2012) Quercetin suppresses drug-resistant spheres via the p38 MAPK\u2013Hsp27 apoptotic pathway in oral cancer cells. PLoS ONE 7(11):e49275","journal-title":"PLoS ONE"},{"key":"2364_CR53","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.intimp.2017.04.022","volume":"48","author":"H Chen","year":"2017","unstructured":"Chen H et al (2017) Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-\u03baB pathway. Int Immunopharmacol 48:110\u2013117","journal-title":"Int Immunopharmacol"},{"key":"2364_CR54","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102435","volume":"111","author":"S Chen","year":"2020","unstructured":"Chen S et al (2020) Selective targeting of PI3K\u03b4 suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases. J Autoimmun 111:102435","journal-title":"J Autoimmun"},{"key":"2364_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2025.167879","author":"B-l Chen","year":"2025","unstructured":"Chen B-l et al (2025) Quercetin induces keratinocytes apoptosis via triple inhibition of Notch, PI3K\/AKT signaling and Glut1 in the treatment of psoriasis. Biochimica Et Biophysica Acta (BBA)-Molecular Basis of Disease. https:\/\/doi.org\/10.1016\/j.bbadis.2025.167879","journal-title":"Biochimica Et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"issue":"1","key":"2364_CR56","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3892\/ijmm.2025.5692","volume":"57","author":"M Cheng","year":"2025","unstructured":"Cheng M et al (2025) Targeting p38 MAPK signaling pathway: quercetin as a novel therapy for TMJ synovitis. Int J Mol Med 57(1):21","journal-title":"Int J Mol Med"},{"issue":"3","key":"2364_CR57","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3390\/pharmaceutics3030497","volume":"3","author":"M Chessa","year":"2011","unstructured":"Chessa M et al (2011) Effect of penetration enhancer containing vesicles on the percutaneous delivery of quercetin through new born pig skin. Pharmaceutics 3(3):497\u2013509","journal-title":"Pharmaceutics"},{"issue":"4","key":"2364_CR58","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2174\/187152810793358741","volume":"9","author":"S Chirumbolo","year":"2010","unstructured":"Chirumbolo S (2010) The role of quercetin, flavonols and flavones in modulating inflammatory cell function. Inflamm Allergy Drug Targets 9(4):263\u2013285","journal-title":"Inflamm Allergy Drug Targets"},{"issue":"12","key":"2364_CR59","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3390\/nu9121304","volume":"9","author":"S-Y Chuang","year":"2017","unstructured":"Chuang S-Y et al (2017) Elucidating the skin delivery of aglycone and glycoside flavonoids: how the structures affect cutaneous absorption. Nutrients 9(12):1304","journal-title":"Nutrients"},{"key":"2364_CR60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynpai.2019.100032","volume":"6","author":"K Chung","year":"2019","unstructured":"Chung K et al (2019) Cathepsin S acts via protease-activated receptor 2 to activate sensory neurons and induce itch-like behaviour. Neurobiol Pain 6:100032","journal-title":"Neurobiol Pain"},{"issue":"2","key":"2364_CR61","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nrd.2015.18","volume":"15","author":"RA Copeland","year":"2016","unstructured":"Copeland RA (2016) The drug\u2013target residence time model: a 10-year retrospective. Nat Rev Drug Discov 15(2):87\u201395","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"2364_CR62","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3390\/antiox10091376","volume":"10","author":"R Costa","year":"2021","unstructured":"Costa R et al (2021) On the development of a cutaneous flavonoid delivery system: advances and limitations. Antioxidants (Basel) 10(9):1376","journal-title":"Antioxidants (Basel)"},{"key":"2364_CR63","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-3-031-08736-3_3","volume-title":"Textbook of dermatologic ultrasound","author":"D Crisan","year":"2022","unstructured":"Crisan D, Crisan M (2022) Dermatologic concepts and terminology. Textbook of dermatologic ultrasound. Springer, pp 21\u201372"},{"issue":"1","key":"2364_CR64","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16010023","volume":"16","author":"EL Crowley","year":"2023","unstructured":"Crowley EL, Gooderham MJ (2023) Phosphodiesterase-4 inhibition in the management of psoriasis. Pharmaceutics 16(1):23","journal-title":"Pharmaceutics"},{"issue":"10","key":"2364_CR65","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.3390\/nu11102288","volume":"11","author":"WM Dabeek","year":"2019","unstructured":"Dabeek WM, Marra MV (2019) Dietary quercetin and kaempferol: bioavailability and potential cardiovascular-related bioactivity in humans. Nutrients 11(10):2288","journal-title":"Nutrients"},{"key":"2364_CR66","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden T, York D, Pedersen L (1993) Particle mesh Ewald: An N log (N) method for Ewald sums in large systems. J Chem Phys 98:10089\u201310089","journal-title":"J Chem Phys"},{"issue":"10","key":"2364_CR67","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/j.bbagen.2016.06.022","volume":"1860","author":"J Das","year":"2016","unstructured":"Das J, Ramani R, Suraju MO (2016) Polyphenol compounds and PKC signaling. Biochimica Et Biophysica Acta (BBA)-General Subjects 1860(10):2107\u20132121","journal-title":"Biochimica Et Biophysica Acta (BBA)-General Subjects"},{"issue":"4","key":"2364_CR68","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1021\/acs.jmedchem.0c01952","volume":"64","author":"RR Davis","year":"2021","unstructured":"Davis RR et al (2021) Structural insights into JAK2 inhibition by ruxolitinib, fedratinib, and derivatives thereof. J Med Chem 64(4):2228\u20132241","journal-title":"J Med Chem"},{"issue":"7","key":"2364_CR69","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1093\/jn\/135.7.1718","volume":"135","author":"VC de Boer","year":"2005","unstructured":"de Boer VC et al (2005) Tissue distribution of quercetin in rats and pigs. J Nutr 135(7):1718\u20131725","journal-title":"J Nutr"},{"issue":"6","key":"2364_CR70","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2021287118","volume":"118","author":"RM de Vries","year":"2021","unstructured":"de Vries RM et al (2021) Cooperativity between the orthosteric and allosteric ligand binding sites of ROR\u03b3t. Proc Natl Acad Sci 118(6):e2021287118","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"2364_CR71","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103532","volume":"23","author":"M De Bondt","year":"2024","unstructured":"De Bondt M et al (2024) Inhibitors of Bruton\u2019s tyrosine kinase as emerging therapeutic strategy in autoimmune diseases. Autoimmun Rev 23(5):103532","journal-title":"Autoimmun Rev"},{"issue":"6","key":"2364_CR72","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/jid.2009.59","volume":"129","author":"A Di Cesare","year":"2009","unstructured":"Di Cesare A, Di Meglio P, Nestle FO (2009) The IL-23\/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129(6):1339\u20131350","journal-title":"J Invest Dermatol"},{"issue":"17","key":"2364_CR73","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.3390\/molecules26175377","volume":"26","author":"MC Dias","year":"2021","unstructured":"Dias MC, Pinto DC, Silva AM (2021) Plant flavonoids: chemical characteristics and biological activity. Molecules 26(17):5377","journal-title":"Molecules"},{"issue":"17","key":"2364_CR74","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179294","volume":"22","author":"K Dopytalska","year":"2021","unstructured":"Dopytalska K et al (2021) The role of epigenetic factors in psoriasis. Int J Mol Sci 22(17):9294","journal-title":"Int J Mol Sci"},{"issue":"14","key":"2364_CR75","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2174\/1389557520666200204121129","volume":"20","author":"M dos Santos Maia","year":"2020","unstructured":"dos Santos Maia M et al (2020) Consensus analyses in molecular docking studies applied to medicinal chemistry. Mini Rev Med Chem 20(14):1322\u20131340","journal-title":"Mini Rev Med Chem"},{"issue":"1","key":"2364_CR76","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41698-021-00215-x","volume":"5","author":"CE Downes","year":"2021","unstructured":"Downes CE et al (2021) Acquired JAK2 mutations confer resistance to JAK inhibitors in cell models of acute lymphoblastic leukemia. NPJ Precis Oncol 5(1):75","journal-title":"NPJ Precis Oncol"},{"issue":"11","key":"2364_CR77","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.3390\/jcm13113091","volume":"13","author":"M Dragotto","year":"2024","unstructured":"Dragotto M et al (2024) Therapeutic potential of targeting the JAK\/STAT pathway in psoriasis: focus on TYK2 inhibition. J Clin Med 13(11):3091","journal-title":"J Clin Med"},{"issue":"4","key":"2364_CR78","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1159\/000509732","volume":"237","author":"A Duvetorp","year":"2021","unstructured":"Duvetorp A et al (2021) Sex and age influence the associated risk of depression in patients with psoriasis: a retrospective population study based on diagnosis and drug-use. Dermatology 237(4):595\u2013602","journal-title":"Dermatology"},{"issue":"1","key":"2364_CR79","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/2008-2231-21-41","volume":"21","author":"A Ebadi","year":"2013","unstructured":"Ebadi A et al (2013) Comparative amino acid decomposition analysis of potent type I p38\u03b1 inhibitors. DARU J Pharm Sci 21(1):41","journal-title":"DARU J Pharm Sci"},{"issue":"8","key":"2364_CR80","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt J et al (2021) AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings. J Chem Inf Model 61(8):3891\u20133898","journal-title":"J Chem Inf Model"},{"key":"2364_CR81","doi-asserted-by":"crossref","unstructured":"Ebrahimi, A., et al., Successful Treatment of. Journal of Reports in Pharmaceutical Sciences, 2024. 12(1).","DOI":"10.5812\/jrps-151889"},{"issue":"1","key":"2364_CR82","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/bjd.18622","volume":"183","author":"A Egeberg","year":"2020","unstructured":"Egeberg A et al (2020) Clinical characteristics, symptoms and burden of psoriasis and atopic dermatitis in adults. Br J Dermatol 183(1):128\u2013138","journal-title":"Br J Dermatol"},{"issue":"1","key":"2364_CR83","doi-asserted-by":"crossref","DOI":"10.1186\/s13568-025-01860-2","volume":"15","author":"SN El Gendy","year":"2025","unstructured":"El Gendy SN et al (2025) Biotransformation of quercetin by Bacillus subtilis and anticancer activity evaluation: in vitro and in silico. AMB Express 15(1):58","journal-title":"AMB Express"},{"issue":"3","key":"2364_CR84","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10787-023-01178-0","volume":"31","author":"OY Elkhawaga","year":"2023","unstructured":"Elkhawaga OY et al (2023) Review of natural compounds for potential psoriasis treatment. Inflammopharmacology 31(3):1183\u20131198","journal-title":"Inflammopharmacology"},{"issue":"8","key":"2364_CR85","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1063\/1.449071","volume":"83","author":"DJ Evans","year":"1985","unstructured":"Evans DJ, Holian BL (1985) The nose\u2013hoover thermostat. J Chem Phys 83(8):4069\u20134074","journal-title":"J Chem Phys"},{"key":"2364_CR86","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.foodres.2017.07.010","volume":"100","author":"M Fan","year":"2017","unstructured":"Fan M et al (2017) Quercetin as a tyrosinase inhibitor: inhibitory activity, conformational change and mechanism. Food Res Int 100:226\u2013233","journal-title":"Food Res Int"},{"key":"2364_CR87","doi-asserted-by":"crossref","unstructured":"Farag, A.G.A., et al., Immunohistochemical study of janus kinase 1\/signal transducer and activator of transcription 3 in psoriasis vulgaris. Clinical, cosmetic and investigational dermatology, 2019: p. 497\u2013508.","DOI":"10.2147\/CCID.S202835"},{"issue":"1","key":"2364_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-73746-5","volume":"14","author":"M Farahani","year":"2024","unstructured":"Farahani M et al (2024) Integrating protein interaction and pathway crosstalk network reveals a promising therapeutic approach for psoriasis through apoptosis induction. Sci Rep 14(1):22103","journal-title":"Sci Rep"},{"key":"2364_CR89","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109112","volume":"111","author":"W Feng","year":"2022","unstructured":"Feng W et al (2022) Study on the effect and mechanism of quercetin in treating gout arthritis. Int Immunopharmacol 111:109112","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"2364_CR90","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11926-007-0075-1","volume":"9","author":"E Fitch","year":"2007","unstructured":"Fitch E et al (2007) Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines. Curr Rheumatol Rep 9(6):461\u2013467","journal-title":"Curr Rheumatol Rep"},{"issue":"5038","key":"2364_CR91","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1126\/science.1749933","volume":"254","author":"H Frauenfelder","year":"1991","unstructured":"Frauenfelder H, Sligar SG, Wolynes PG (1991) The energy landscapes and motions of proteins. Science 254(5038):1598\u20131603","journal-title":"Science"},{"issue":"22","key":"2364_CR92","volume":"25","author":"O-D Fren\u021b","year":"2024","unstructured":"Fren\u021b O-D et al (2024) A systematic review: quercetin\u2014secondary metabolite of the flavonol class, with multiple health benefits and low bioavailability. Int J Mol Sci 25(22):12091","journal-title":"Int J Mol Sci"},{"issue":"9","key":"2364_CR93","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1038\/jid.2011.140","volume":"131","author":"JS Fridman","year":"2011","unstructured":"Fridman JS et al (2011) Preclinical evaluation of local JAK1 and JAK2 inhibition in cutaneous inflammation. J Invest Dermatol 131(9):1838\u20131844","journal-title":"J Invest Dermatol"},{"key":"2364_CR94","volume-title":"Urologic Oncology: Seminars and Original Investigations","author":"MA Furrer","year":"2018","unstructured":"Furrer MA et al (2018) Incidence and perioperative risk factors for early acute kidney injury after radical cystectomy and urinary diversion. Urologic Oncology: Seminars and Original Investigations. Elsevier"},{"issue":"1","key":"2364_CR95","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2340\/00015555-2808","volume":"98","author":"K Furue","year":"2018","unstructured":"Furue K et al (2018) Highlighting interleukin-36 signalling in plaque psoriasis and pustular psoriasis. Acta Derm Venereol 98(1):5\u201313","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"2364_CR96","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jaad.2021.09.074","volume":"87","author":"SD Gadola","year":"2022","unstructured":"Gadola SD et al (2022) An open-label phase 2a study investigating the efficacy and safety of a cathepsin S inhibitor in patients with moderate-to-severe psoriasis. J Am Acad Dermatol 87(5):1089\u20131091","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2364_CR97","doi-asserted-by":"crossref","first-page":"27","DOI":"10.26599\/FSHW.2022.9250003","volume":"13","author":"R Gan","year":"2024","unstructured":"Gan R et al (2024) Natural sources, refined extraction, biosynthesis, metabolism, and bioactivities of dietary polymethoxyflavones (PMFs). Food Sci Hum Wellness 13(1):27\u201349","journal-title":"Food Sci Hum Wellness"},{"key":"2364_CR98","volume":"16","author":"H Gao","year":"2025","unstructured":"Gao H et al (2025) Cathepsin S: molecular mechanisms in inflammatory and immunological processes. Front Immunol 16:1600206","journal-title":"Front Immunol"},{"key":"2364_CR99","volume-title":"Homology molecular modeling-perspectives and applications","author":"B Gautam","year":"2020","unstructured":"Gautam B (2020) Energy minimization. Homology molecular modeling-perspectives and applications"},{"issue":"5","key":"2364_CR100","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1111\/jcmm.14995","volume":"24","author":"YW Ge","year":"2020","unstructured":"Ge YW et al (2020) Quercetin inhibits macrophage polarization through the p-38\u03b1\/\u03b2 signalling pathway and regulates OPG\/RANKL balance in a mouse skull model. J Cell Mol Med 24(5):3203\u20133216","journal-title":"J Cell Mol Med"},{"key":"2364_CR101","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114622","volume":"155","author":"D Geetha","year":"2025","unstructured":"Geetha D, Skaria T (2025) Cathepsin S: a key drug target and signalling hub in immune system diseases. Int Immunopharmacol 155:114622","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"2364_CR102","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1021\/jm500669m","volume":"58","author":"DM George","year":"2015","unstructured":"George DM et al (2015) Discovery of selective and orally bioavailable protein kinase C\u03b8 (PKC\u03b8) inhibitors from a fragment hit. J Med Chem 58(1):222\u2013236","journal-title":"J Med Chem"},{"issue":"11","key":"2364_CR103","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.3390\/ijms21113793","volume":"21","author":"A Gimeno","year":"2020","unstructured":"Gimeno A et al (2020) Prediction of novel inhibitors of the main protease (M-pro) of SARS-CoV-2 through consensus docking and drug reposition. Int J Mol Sci 21(11):3793","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2364_CR104","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.3390\/jcm9113594","volume":"9","author":"P Gisondi","year":"2020","unstructured":"Gisondi P, Bellinato F, Girolomoni G (2020) Topographic differential diagnosis of chronic plaque psoriasis: challenges and tricks. J Clin Med 9(11):3594","journal-title":"J Clin Med"},{"key":"2364_CR105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.fct.2014.01.016","volume":"66","author":"C Giuliani","year":"2014","unstructured":"Giuliani C et al (2014) The flavonoid quercetin inhibits thyroid-restricted genes expression and thyroid function. Food Chem Toxicol 66:23\u201329","journal-title":"Food Chem Toxicol"},{"issue":"8","key":"2364_CR106","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1074\/jbc.M114.595181","volume":"290","author":"ER Goedken","year":"2015","unstructured":"Goedken ER et al (2015) Tricyclic covalent inhibitors selectively target Jak3 through an active site thiol. J Biol Chem 290(8):4573\u20134589","journal-title":"J Biol Chem"},{"issue":"2","key":"2364_CR107","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1021\/acs.jcim.9b00558","volume":"60","author":"R Gonz\u00e1lez-Alem\u00e1n","year":"2019","unstructured":"Gonz\u00e1lez-Alem\u00e1n R et al (2019) Quality threshold clustering of molecular dynamics: a word of caution. J Chem Inf Model 60(2):467\u2013472","journal-title":"J Chem Inf Model"},{"issue":"1","key":"2364_CR108","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/pro.3934","volume":"30","author":"DS Goodsell","year":"2021","unstructured":"Goodsell DS et al (2021) The AutoDock suite at 30. Protein Sci 30(1):31\u201343","journal-title":"Protein Sci"},{"issue":"2","key":"2364_CR109","volume":"8","author":"C Guillet","year":"2022","unstructured":"Guillet C et al (2022) The impact of gender and sex in psoriasis: what to be aware of when treating women with psoriasis. Int J Womens Dermatol 8(2):e010","journal-title":"Int J Womens Dermatol"},{"issue":"17","key":"2364_CR110","doi-asserted-by":"crossref","first-page":"7923","DOI":"10.1021\/acs.jmedchem.9b00687","volume":"62","author":"Y Guo","year":"2019","unstructured":"Guo Y et al (2019) Discovery of zanubrutinib (BGB-3111), a novel, potent, and selective covalent inhibitor of Bruton\u2019s tyrosine kinase. J Med Chem 62(17):7923\u20137940","journal-title":"J Med Chem"},{"issue":"5","key":"2364_CR111","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1080\/10408398.2022.2115456","volume":"64","author":"B Guo","year":"2022","unstructured":"Guo B et al (2022) Recent insights into oxidative metabolism of quercetin: catabolic profiles, degradation pathways, catalyzing metalloenzymes and molecular mechanisms. Crit Rev Food Sci Nutr 64(5):1312\u20131339","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"2364_CR112","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","volume":"8","author":"J Guo","year":"2023","unstructured":"Guo J et al (2023a) Signaling pathways and targeted therapies for psoriasis. Signal Transduct Target Ther 8(1):437","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"2364_CR113","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1039\/D2FO03417D","volume":"14","author":"S Guo","year":"2023","unstructured":"Guo S et al (2023b) Eriodictyol: a review of its pharmacological activities and molecular mechanisms related to ischemic stroke. Food Funct 14(4):1851\u20131868","journal-title":"Food Funct"},{"key":"2364_CR114","doi-asserted-by":"crossref","DOI":"10.1016\/j.prmcm.2024.100463","volume":"12","author":"A Gupta","year":"2024","unstructured":"Gupta A et al (2024) Treatment strategies for psoriasis using flavonoids from traditional Chinese medicine. Pharmacological Research-Modern Chinese Medicine 12:100463","journal-title":"Pharmacological Research-Modern Chinese Medicine"},{"issue":"2","key":"2364_CR115","first-page":"96","volume":"3","author":"H Guven","year":"2019","unstructured":"Guven H, Arici A, Simsek O (2019) Flavonoids in our foods: a short review. J Basic Clin Health Sci 3(2):96\u2013106","journal-title":"J Basic Clin Health Sci"},{"issue":"5\u20136","key":"2364_CR116","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P","volume":"17","author":"TA Halgren","year":"1996","unstructured":"Halgren TA (1996) Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J Comput Chem 17(5\u20136):490\u2013519","journal-title":"J Comput Chem"},{"key":"2364_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.prenap.2025.100206","author":"AMW Hasan","year":"2025","unstructured":"Hasan AMW et al (2025) Quercetin promises anticancer activity through PI3K-AKT-mTOR pathway: a literature review. Pharmacol Res Nat Prod. https:\/\/doi.org\/10.1016\/j.prenap.2025.100206","journal-title":"Pharmacol Res Nat Prod"},{"key":"2364_CR118","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejpb.2016.08.011","volume":"108","author":"T Hatahet","year":"2016","unstructured":"Hatahet T et al (2016) Quercetin topical application, from conventional dosage forms to nanodosage forms. Eur J Pharm Biopharm 108:41\u201353","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"2364_CR119","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s11596-013-1164-1","volume":"33","author":"Q He","year":"2013","unstructured":"He Q et al (2013) IL-36 cytokine expression and its relationship with p38 MAPK and NF-\u03baB pathways in psoriasis vulgaris skin lesions. Journal of Huazhong University of Science and Technology [medical Sciences] 33(4):594\u2013599","journal-title":"Journal of Huazhong University of Science and Technology [medical Sciences]"},{"key":"2364_CR120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.genhosppsych.2022.01.006","volume":"75","author":"TL Hedemann","year":"2022","unstructured":"Hedemann TL et al (2022) Associations between psoriasis and mental illness: an update for clinicians. Gen Hosp Psychiatry 75:30\u201337","journal-title":"Gen Hosp Psychiatry"},{"key":"2364_CR121","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.biopha.2019.01.035","volume":"111","author":"V Heger","year":"2019","unstructured":"Heger V et al (2019) Quercetin based derivatives as sirtuin inhibitors. Biomed Pharmacother 111:1326\u20131333","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"2364_CR122","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41592-022-01685-y","volume":"20","author":"ML Hekkelman","year":"2023","unstructured":"Hekkelman ML et al (2023) AlphaFill: enriching AlphaFold models with ligands and cofactors. Nat Methods 20(2):205\u2013213","journal-title":"Nat Methods"},{"issue":"1","key":"2364_CR123","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.febslet.2010.11.031","volume":"585","author":"KM Henkels","year":"2011","unstructured":"Henkels KM et al (2011) IL-8-induced neutrophil chemotaxis is mediated by Janus kinase 3 (JAK3). FEBS Lett 585(1):159\u2013166","journal-title":"FEBS Lett"},{"issue":"9","key":"2364_CR124","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.4049\/jimmunol.1200901","volume":"190","author":"T Hirai","year":"2013","unstructured":"Hirai T et al (2013) Cathepsin K is involved in development of psoriasis-like skin lesions through TLR-dependent Th17 activation. J Immunol 190(9):4805\u20134811","journal-title":"J Immunol"},{"issue":"12","key":"2364_CR125","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.3390\/pharmaceutics14122818","volume":"14","author":"V Hmingthansanga","year":"2022","unstructured":"Hmingthansanga V et al (2022) Improved topical drug delivery: role of permeation enhancers and advanced approaches. Pharmaceutics 14(12):2818","journal-title":"Pharmaceutics"},{"key":"2364_CR126","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v101.565","author":"S H\u00f6lsken","year":"2021","unstructured":"H\u00f6lsken S et al (2021) Common fundamentals of psoriasis and depression. Acta Derm Venereol. https:\/\/doi.org\/10.2340\/actadv.v101.565","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"2364_CR127","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.4049\/jimmunol.176.6.3635","volume":"176","author":"NJ Horwood","year":"2006","unstructured":"Horwood NJ et al (2006) Bruton\u2019s tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL-6, production. J Immunol 176(6):3635\u20133641","journal-title":"J Immunol"},{"issue":"2","key":"2364_CR128","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1021\/ci300399w","volume":"53","author":"DR Houston","year":"2013","unstructured":"Houston DR, Walkinshaw MD (2013) Consensus docking: improving the reliability of docking in a virtual screening context. J Chem Inf Model 53(2):384\u2013390","journal-title":"J Chem Inf Model"},{"key":"2364_CR129","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.3389\/fimmu.2019.02342","volume":"10","author":"MD Howell","year":"2019","unstructured":"Howell MD, Kuo FI, Smith PA (2019) Targeting the Janus kinase family in autoimmune skin diseases. Front Immunol 10:2342","journal-title":"Front Immunol"},{"issue":"2","key":"2364_CR130","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/bjd.12654","volume":"170","author":"L Hsu","year":"2014","unstructured":"Hsu L, Snodgrass BT, Armstrong AW (2014) Antidrug antibodies in psoriasis: a systematic review. Br J Dermatol 170(2):261\u2013273","journal-title":"Br J Dermatol"},{"key":"2364_CR131","doi-asserted-by":"crossref","unstructured":"Hsu, L. and A.W. Armstrong, JAK inhibitors: treatment efficacy and safety profile in patients with psoriasis. Journal of immunology research, 2014. 2014(1): p. 283617.","DOI":"10.1155\/2014\/283617"},{"issue":"1","key":"2364_CR132","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X et al (2021a) The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther 6(1):402","journal-title":"Signal Transduct Target Ther"},{"key":"2364_CR133","volume":"12","author":"P Hu","year":"2021","unstructured":"Hu P et al (2021b) The role of helper T cells in psoriasis. Front Immunol 12:788940","journal-title":"Front Immunol"},{"issue":"7","key":"2364_CR134","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0969-2126(03)00123-0","volume":"11","author":"Q Huai","year":"2003","unstructured":"Huai Q et al (2003) Three-dimensional structures of PDE4D in complex with roliprams and implication on inhibitor selectivity. Structure 11(7):865\u2013873","journal-title":"Structure"},{"issue":"6","key":"2364_CR135","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1021\/jm051273d","volume":"49","author":"Q Huai","year":"2006","unstructured":"Huai Q et al (2006) Enantiomer discrimination illustrated by the high resolution crystal structures of type 4 phosphodiesterase. J Med Chem 49(6):1867\u20131873","journal-title":"J Med Chem"},{"issue":"25","key":"2364_CR136","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/jcc.23354","volume":"34","author":"J Huang","year":"2013","unstructured":"Huang J, MacKerell AD Jr (2013) CHARMM36 all\u2010atom additive protein force field: validation based on comparison to NMR data. J Comput Chem 34(25):2135\u20132145","journal-title":"J Comput Chem"},{"issue":"21","key":"2364_CR137","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.3390\/jcm11216296","volume":"11","author":"Y-S Huang","year":"2022","unstructured":"Huang Y-S et al (2022) Ultrasound can be usefully integrated with the clinical assessment of nail and enthesis involvement in psoriasis and psoriatic arthritis. J Clin Med 11(21):6296","journal-title":"J Clin Med"},{"issue":"5","key":"2364_CR138","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.1538-7836.2003.00212.x","volume":"1","author":"GP Hubbard","year":"2003","unstructured":"Hubbard GP et al (2003) Quercetin inhibits collagen-stimulated platelet activation through inhibition of multiple components of the glycoprotein VI signaling pathway. J Thromb Haemost 1(5):1079\u20131088","journal-title":"J Thromb Haemost"},{"key":"2364_CR139","first-page":"54","volume":"8","author":"R Huey","year":"2008","unstructured":"Huey R, Morris GM (2008) Using AutoDock 4 with AutoDocktools: a tutorial. The Scripps Research Institute, USA 8:54\u201356","journal-title":"The Scripps Research Institute, USA"},{"issue":"1","key":"2364_CR140","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12906-021-03359-2","volume":"21","author":"A Ibezim","year":"2021","unstructured":"Ibezim A et al (2021) A computational multi-targeting approach for drug repositioning for psoriasis treatment. BMC Complement Med Ther 21(1):193","journal-title":"BMC Complement Med Ther"},{"key":"2364_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2025.152681","author":"JD Isaacs","year":"2025","unstructured":"Isaacs JD (2025) Bruton\u2019s tyrosine kinase-A new target for immune mediated inflammatory diseases? Semin Arthritis Rheum. https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152681","journal-title":"Semin Arthritis Rheum"},{"key":"2364_CR142","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2012.00273","volume":"3","author":"N Isakov","year":"2012","unstructured":"Isakov N, Altman A (2012) PKC-theta-mediated signal delivery from the TCR\/CD28 surface receptors. Front Immunol 3:273","journal-title":"Front Immunol"},{"issue":"6","key":"2364_CR143","doi-asserted-by":"crossref","first-page":"814","DOI":"10.2174\/1389201023666220617151552","volume":"24","author":"AR Issahaku","year":"2023","unstructured":"Issahaku AR, Soliman ME (2023) Investigating the impact of covalent and non-covalent binding modes of inhibitors on Bruton\u2019s tyrosine kinase in the treatment of B cell malignancies-computational insights. Curr Pharm Biotechnol 24(6):814\u2013824","journal-title":"Curr Pharm Biotechnol"},{"issue":"06","key":"2364_CR144","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/a-0797-3657","volume":"69","author":"N Jaiswal","year":"2019","unstructured":"Jaiswal N et al (2019) An overview on genistein and its various formulations. Drug Res (Stuttg) 69(06):305\u2013313","journal-title":"Drug Res (Stuttg)"},{"issue":"4","key":"2364_CR145","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/jdv.18850","volume":"37","author":"K Jaworecka","year":"2023","unstructured":"Jaworecka K et al (2023) Characteristics of pruritus in various clinical variants of psoriasis: final report of the binational, multicentre, cross-sectional study. J Eur Acad Dermatol Venereol 37(4):787\u2013795","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"19","key":"2364_CR146","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.3390\/molecules27196211","volume":"27","author":"W Jia","year":"2022","unstructured":"Jia W et al (2022) Discovery of novel PI3K\u03b4 inhibitors based on the p110\u03b4 crystal structure. Molecules 27(19):6211","journal-title":"Molecules"},{"issue":"20","key":"2364_CR147","volume":"25","author":"W Jia","year":"2024","unstructured":"Jia W et al (2024) In silico discovery of a novel PI3K\u03b4 inhibitor incorporating 3, 5, 7-trihydroxychroman-4-one targeting diffuse large B-cell lymphoma. Int J Mol Sci 25(20):11250","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2364_CR148","volume":"11","author":"W Jiang","year":"2016","unstructured":"Jiang W et al (2016) Quercetin protects against okadaic acid-induced injury via MAPK and PI3K\/Akt\/GSK3\u03b2 signaling pathways in HT22 hippocampal neurons. PLoS ONE 11(4):e0152371","journal-title":"PLoS ONE"},{"issue":"6","key":"2364_CR149","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.126967","volume":"30","author":"X Jiang","year":"2020","unstructured":"Jiang X et al (2020) A novel series of cysteine-dependent, allosteric inverse agonists of the nuclear receptor ROR\u03b3t. Bioorg Med Chem Lett 30(6):126967","journal-title":"Bioorg Med Chem Lett"},{"key":"2364_CR150","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106287","volume":"182","author":"D Jing","year":"2022","unstructured":"Jing D et al (2022) Quercetin encapsulated in folic acid-modified liposomes is therapeutic against osteosarcoma by non-covalent binding to the JH2 domain of JAK2 via the JAK2-STAT3-PDL1. Pharmacol Res 182:106287","journal-title":"Pharmacol Res"},{"key":"2364_CR151","doi-asserted-by":"publisher","DOI":"10.5012\/bkcs.2014.35.9.2787","author":"HN Jnawali","year":"2014","unstructured":"Jnawali HN et al (2014) Effect of quercetin in the UV-irradiated human keratinocyte HaCaT cells and a model of its binding to p38 MAPK. Bull Korean Chem Soc. https:\/\/doi.org\/10.5012\/bkcs.2014.35.9.2787","journal-title":"Bull Korean Chem Soc"},{"issue":"11","key":"2364_CR152","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","volume":"29","author":"S Jo","year":"2008","unstructured":"Jo S et al (2008) CHARMM-GUI: a web-based graphical user interface for CHARMM. J Comput Chem 29(11):1859\u20131865","journal-title":"J Comput Chem"},{"key":"2364_CR153","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.tifs.2021.11.032","volume":"119","author":"K Kandemir","year":"2022","unstructured":"Kandemir K et al (2022) Recent advances on the improvement of quercetin bioavailability. Trends Food Sci Tech 119:192\u2013200","journal-title":"Trends Food Sci Tech"},{"issue":"Special Issue N","key":"2364_CR154","doi-asserted-by":"crossref","first-page":"146","DOI":"10.12944\/CRNFSJ.4.Special-Issue-October.20","volume":"4","author":"MB Ka\u015f\u0131kc\u0131","year":"2016","unstructured":"Ka\u015f\u0131kc\u0131 MB, Ba\u011fdatl\u0131o\u011flu N (2016) Bioavailability of quercetin. Curr Res Nutr Food Sci J 4(Special Issue Nutrition in Conference October 2016):146\u2013151","journal-title":"Curr Res Nutr Food Sci J"},{"issue":"11","key":"2364_CR155","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1016\/j.bmc.2016.04.008","volume":"24","author":"T Katoh","year":"2016","unstructured":"Katoh T et al (2016) Discovery and optimization of 1, 7-disubstituted-2, 2-dimethyl-2, 3-dihydroquinazolin-4 (1H)-ones as potent and selective PKC\u03b8 inhibitors. Bioorg Med Chem 24(11):2466\u20132475","journal-title":"Bioorg Med Chem"},{"issue":"3","key":"2364_CR156","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0190-9622(99)70359-2","volume":"41","author":"HI Katz","year":"1999","unstructured":"Katz HI, Waalen J, Leach EE (1999) Acitretin in psoriasis: an overview of adverse effects. J Am Acad Dermatol 41(3):S7\u2013S12","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"2364_CR157","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2174\/156802607779941242","volume":"7","author":"H Ke","year":"2007","unstructured":"Ke H, Wang H (2007) Crystal structures of phosphodiesterases and implications on substrate specificity and inhibitor selectivity. Curr Top Med Chem 7(4):391\u2013403","journal-title":"Curr Top Med Chem"},{"issue":"8","key":"2364_CR158","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190720","volume":"39","author":"M Kedhari Sundaram","year":"2019","unstructured":"Kedhari Sundaram M et al (2019) Quercetin modulates signaling pathways and induces apoptosis in cervical cancer cells. Biosci Rep 39(8):BSR20190720","journal-title":"Biosci Rep"},{"issue":"7","key":"2364_CR159","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/sj.bjp.0706246","volume":"145","author":"D Kempuraj","year":"2005","unstructured":"Kempuraj D et al (2005) Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. Br J Pharmacol 145(7):934\u2013944","journal-title":"Br J Pharmacol"},{"issue":"4","key":"2364_CR160","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3892\/ijmm.2014.1658","volume":"33","author":"GT Kim","year":"2014","unstructured":"Kim GT et al (2014) Quercetin regulates the sestrin 2-AMPK-p38 MAPK signaling pathway and induces apoptosis by increasing the generation of intracellular ROS in a p53-independent manner. Int J Mol Med 33(4):863\u2013869","journal-title":"Int J Mol Med"},{"issue":"D1","key":"2364_CR161","doi-asserted-by":"crossref","first-page":"D1102","DOI":"10.1093\/nar\/gky1033","volume":"47","author":"S Kim","year":"2019","unstructured":"Kim S et al (2019) PubChem 2019 update: improved access to chemical data. Nucleic Acids Res 47(D1):D1102\u2013D1109","journal-title":"Nucleic Acids Res"},{"key":"2364_CR162","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3375","author":"CE Kleyn","year":"2020","unstructured":"Kleyn CE et al (2020) Psoriasis and mental health workshop report: exploring the links between psychosocial factors, psoriasis, neuroinflammation and cardiovascular disease risk. Acta Derm Venereol. https:\/\/doi.org\/10.2340\/00015555-3375","journal-title":"Acta Derm Venereol"},{"issue":"21","key":"2364_CR163","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1111\/bph.16104","volume":"181","author":"KE Knockenhauer","year":"2024","unstructured":"Knockenhauer KE, Copeland RA (2024) The importance of binding kinetics and drug-target residence time in pharmacology. Br J Pharmacol 181(21):4103\u20134116","journal-title":"Br J Pharmacol"},{"issue":"10","key":"2364_CR164","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.bcp.2004.06.030","volume":"68","author":"W-C Ko","year":"2004","unstructured":"Ko W-C et al (2004) Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure\u2013activity relationships. Biochem Pharmacol 68(10):2087\u20132094","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2364_CR165","volume":"2011","author":"W-C Ko","year":"2011","unstructured":"Ko W-C et al (2011) Biochanin A, a phytoestrogenic isoflavone with selective inhibition of phosphodiesterase 4, suppresses ovalbumin\u2010induced airway hyperresponsiveness. Evid Based Complement Alternat Med 2011(1):635058","journal-title":"Evid Based Complement Alternat Med"},{"key":"2364_CR166","volume-title":"Nutrient metabolism: structures, functions, and genes","author":"M Kohlmeier","year":"2015","unstructured":"Kohlmeier M (2015) Nutrient metabolism: structures, functions, and genes. Academic Press"},{"issue":"6","key":"2364_CR167","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.3390\/molecules16065159","volume":"16","author":"D Kong","year":"2011","unstructured":"Kong D et al (2011a) Inhibitory activity of flavonoids against class I phosphatidylinositol 3-kinase isoforms. Molecules 16(6):5159\u20135167","journal-title":"Molecules"},{"issue":"11","key":"2364_CR168","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/ni.2120","volume":"12","author":"K-F Kong","year":"2011","unstructured":"Kong K-F et al (2011b) A motif in the V3 domain of the kinase PKC-\u03b8 determines its localization in the immunological synapse and functions in T cells via association with CD28. Nat Immunol 12(11):1105\u20131112","journal-title":"Nat Immunol"},{"issue":"1","key":"2364_CR169","doi-asserted-by":"publisher","first-page":"9088","DOI":"10.1038\/s41598-017-09586-3","volume":"7","author":"X Kong","year":"2017","unstructured":"Kong X et al (2017) How does the L884P mutation confer resistance to type-II inhibitors of JAK2 kinase: a comprehensive molecular modeling study. Sci Rep 7(1):9088","journal-title":"Sci Rep"},{"key":"2364_CR170","volume":"26","author":"Y Kong","year":"2022","unstructured":"Kong Y et al (2022) Effects of dietary quercetin on growth, antioxidant capacity, immune response and immune-related gene expression in snakehead fish, Channa argus. Aquac Rep 26:101314","journal-title":"Aquac Rep"},{"issue":"2","key":"2364_CR171","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s11596-023-2721-x","volume":"43","author":"S-M Kong","year":"2023","unstructured":"Kong S-M et al (2023) Chemerin exacerbates psoriasis by stimulating keratinocyte proliferation and cytokine production. Curr Med Sci 43(2):399\u2013408","journal-title":"Curr Med Sci"},{"issue":"1","key":"2364_CR172","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.canlet.2008.09.027","volume":"275","author":"T Kumamoto","year":"2009","unstructured":"Kumamoto T, Fujii M, Hou D-X (2009) Myricetin directly targets JAK1 to inhibit cell transformation. Cancer Lett 275(1):17\u201326","journal-title":"Cancer Lett"},{"issue":"1","key":"2364_CR173","volume":"2013","author":"S Kumar","year":"2013","unstructured":"Kumar S, Pandey AK (2013) Chemistry and biological activities of flavonoids: an overview. Sci World J 2013(1):162750","journal-title":"Sci World J"},{"issue":"5","key":"2364_CR174","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.62347\/JCGQ1004","volume":"15","author":"K Kunieda","year":"2025","unstructured":"Kunieda K et al (2025) A long-lasting PI3K\u03b4 inhibitor zandelisib forms a water-shielded hydrogen bond with p110\u03b4 and demonstrates sustained inhibitory effects. Am J Cancer Res 15(5):2097","journal-title":"Am J Cancer Res"},{"issue":"1","key":"2364_CR175","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s13555-019-00347-w","volume":"10","author":"A Kvist-Hansen","year":"2020","unstructured":"Kvist-Hansen A, Hansen PR, Skov L (2020) Systemic treatment of psoriasis with JAK inhibitors: a review. Dermatol Ther 10(1):29\u201342","journal-title":"Dermatol Ther"},{"key":"2364_CR176","volume":"13","author":"S Kwon","year":"2022","unstructured":"Kwon S (2022) Molecular dissection of Janus kinases as drug targets for inflammatory diseases. Front Immunol 13:1075192","journal-title":"Front Immunol"},{"issue":"12","key":"2364_CR177","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.4049\/jimmunol.1102941","volume":"188","author":"M-J Kwon","year":"2012","unstructured":"Kwon M-J et al (2012) Protein kinase C-\u03b8 promotes Th17 differentiation via upregulation of Stat3. J Immunol 188(12):5887\u20135897","journal-title":"J Immunol"},{"issue":"6","key":"2364_CR178","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1261\/rna.1563609","volume":"15","author":"PT Lang","year":"2009","unstructured":"Lang PT et al (2009) DOCK 6: combining techniques to model RNA\u2013small molecule complexes. RNA 15(6):1219\u20131230","journal-title":"RNA"},{"issue":"4","key":"2364_CR179","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.3390\/ijms24043293","volume":"24","author":"MK Lawson","year":"2023","unstructured":"Lawson MK (2023) Improvement of therapeutic value of quercetin with chitosan nanoparticle delivery systems and potential applications. Int J Mol Sci 24(4):3293","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2364_CR180","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/bioinformatics\/btz656","volume":"36","author":"A Lee","year":"2020","unstructured":"Lee A, Kim D (2020) CRDS: consensus reverse docking system for target fishing. Bioinformatics 36(3):959\u2013960","journal-title":"Bioinformatics"},{"issue":"17","key":"2364_CR181","volume":"24","author":"H-J Lee","year":"2023","unstructured":"Lee H-J, Kim M (2023) Challenges and future trends in the treatment of psoriasis. Int J Mol Sci 24(17):13313","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2364_CR182","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1158\/0008-5472.CAN-07-3140","volume":"68","author":"KW Lee","year":"2008","unstructured":"Lee KW et al (2008) Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine. Cancer Res 68(3):946\u2013955","journal-title":"Cancer Res"},{"issue":"12","key":"2364_CR183","doi-asserted-by":"crossref","first-page":"6428","DOI":"10.3390\/ijms22126428","volume":"22","author":"H Lee","year":"2021","unstructured":"Lee H et al (2021) Skullcapflavone II suppresses TNF-\u03b1\/IFN-\u03b3-induced TARC, MDC, and CTSS production in HaCaT cells. Int J Mol Sci 22(12):6428","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2364_CR184","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.it.2024.12.001","volume":"46","author":"C-C Lee","year":"2025","unstructured":"Lee C-C et al (2025) Generalized pustular psoriasis: immunological mechanisms, genetics, and emerging therapeutics. Trends Immunol 46(1):74\u201389","journal-title":"Trends Immunol"},{"issue":"28","key":"2364_CR185","doi-asserted-by":"crossref","first-page":"11618","DOI":"10.1074\/jbc.M117.789024","volume":"292","author":"X Li","year":"2017","unstructured":"Li X et al (2017) Structural studies unravel the active conformation of apo ROR\u03b3t nuclear receptor and a common inverse agonism of two diverse classes of ROR\u03b3t inhibitors. J Biol Chem 292(28):11618\u201311630","journal-title":"J Biol Chem"},{"key":"2364_CR186","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3389\/fphar.2018.01048","volume":"9","author":"H Li","year":"2018","unstructured":"Li H, Zuo J, Tang W (2018) Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases. Front Pharmacol 9:1048","journal-title":"Front Pharmacol"},{"issue":"1","key":"2364_CR187","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1080\/10717544.2021.1927244","volume":"28","author":"H Li","year":"2021","unstructured":"Li H et al (2021) Enhancement of oral bioavailability of quercetin by metabolic inhibitory nanosuspensions compared to conventional nanosuspensions. Drug Deliv 28(1):1226\u20131236","journal-title":"Drug Deliv"},{"issue":"10","key":"2364_CR188","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00403-024-03425-y","volume":"316","author":"Z Li","year":"2024","unstructured":"Li Z et al (2024) Clinical features and effects of cyclosporine in the treatment of psoriasis: a systemic review and meta-analysis. Arch Dermatol Res 316(10):705","journal-title":"Arch Dermatol Res"},{"key":"2364_CR189","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejmech.2013.03.070","volume":"67","author":"J Liang","year":"2013","unstructured":"Liang J et al (2013) Lead identification of novel and selective TYK2 inhibitors. Eur J Med Chem 67:175\u2013187","journal-title":"Eur J Med Chem"},{"issue":"4","key":"2364_CR190","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/imm.12510","volume":"146","author":"PS Lim","year":"2015","unstructured":"Lim PS, Sutton CR, Rao S (2015) Protein kinase C in the immune system: from signalling to chromatin regulation. Immunology 146(4):508\u2013522","journal-title":"Immunology"},{"issue":"7","key":"2364_CR191","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2174\/156800908786241050","volume":"8","author":"Y Lin","year":"2008","unstructured":"Lin Y et al (2008) Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets 8(7):634\u2013646","journal-title":"Curr Cancer Drug Targets"},{"key":"2364_CR192","volume":"9","author":"TE Lin","year":"2018","unstructured":"Lin TE et al (2018) A novel selective JAK2 inhibitor identified using pharmacological interactions. Front Pharmacol 9:1379","journal-title":"Front Pharmacol"},{"key":"2364_CR193","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jare.2024.05.010","volume":"70","author":"J Lin","year":"2025","unstructured":"Lin J et al (2025) Quercetin, a natural flavonoid, protects against hepatic ischemia\u2013reperfusion injury via inhibiting Caspase-8\/ASC dependent macrophage pyroptosis. J Adv Res 70:555\u2013569","journal-title":"J Adv Res"},{"key":"2364_CR194","volume":"11","author":"T Liu","year":"2020","unstructured":"Liu T et al (2020a) The IL-23\/IL-17 pathway in inflammatory skin diseases: from bench to bedside. Front Immunol 11:594735","journal-title":"Front Immunol"},{"key":"2364_CR195","first-page":"204201882092055","volume":"11","author":"Z-M Liu","year":"2020","unstructured":"Liu Z-M et al (2020b) Effect of whole soy and isoflavones daidzein on bone turnover and inflammatory markers: a 6-month double-blind, randomized controlled trial in Chinese postmenopausal women who are equol producers. Therapeutic Advances in Endocrinology and Metabolism 11:2042018820920555","journal-title":"Therapeutic Advances in Endocrinology and Metabolism"},{"issue":"14","key":"2364_CR196","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.1303392110","volume":"110","author":"I L\u00f3pez-S\u00e1nchez","year":"2013","unstructured":"L\u00f3pez-S\u00e1nchez I et al (2013) Protein kinase C-theta (PKC\u03b8) phosphorylates and inhibits the guanine exchange factor, GIV\/Girdin. Proc Natl Acad Sci U S A 110(14):5510\u20135515","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2364_CR197","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.730257","volume":"12","author":"W L\u00f6scher","year":"2021","unstructured":"L\u00f6scher W (2021) Single-target versus multi-target drugs versus combinations of drugs with multiple targets: preclinical and clinical evidence for the treatment or prevention of epilepsy. Front Pharmacol 12:730257","journal-title":"Front Pharmacol"},{"issue":"1","key":"2364_CR198","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","volume":"32","author":"MA Lowes","year":"2014","unstructured":"Lowes MA, Suarez-Farinas M, Krueger JG (2014) Immunology of psoriasis. Annu Rev Immunol 32(1):227\u2013255","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"2364_CR199","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1182\/blood-2005-06-2413","volume":"107","author":"IS Lucet","year":"2006","unstructured":"Lucet IS et al (2006) The structural basis of Janus kinase 2 inhibition by a potent and specific pan-Janus kinase inhibitor. Blood 107(1):176\u2013183","journal-title":"Blood"},{"issue":"5","key":"2364_CR200","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/bjd.14399","volume":"174","author":"V Ludbrook","year":"2016","unstructured":"Ludbrook V et al (2016) Investigation of selective JAK1 inhibitor GSK2586184 for the treatment of psoriasis in a randomized placebo\u2010controlled phase IIa study. Br J Dermatol 174(5):985\u2013995","journal-title":"Br J Dermatol"},{"issue":"22","key":"2364_CR201","doi-asserted-by":"crossref","first-page":"8025","DOI":"10.1073\/pnas.1401180111","volume":"111","author":"PJ Lupardus","year":"2014","unstructured":"Lupardus PJ et al (2014) Structure of the pseudokinase\u2013kinase domains from protein kinase TYK2 reveals a mechanism for Janus kinase (JAK) autoinhibition. Proc Natl Acad Sci U S A 111(22):8025\u20138030","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"2364_CR202","doi-asserted-by":"crossref","first-page":"8052","DOI":"10.3390\/ijms25158052","volume":"25","author":"M Lusardi","year":"2024","unstructured":"Lusardi M et al (2024) PDE4D: a multipurpose pharmacological target. Int J Mol Sci 25(15):8052","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2364_CR203","doi-asserted-by":"crossref","first-page":"26884","DOI":"10.31083\/FBL26884","volume":"30","author":"J Ma","year":"2025","unstructured":"Ma J et al (2025) Inhibition of PI3K\/AKT\/GLUT1 signaling pathway by quercetin in the treatment of psoriasis. Front Biosci-Landmark 30(2):26884","journal-title":"Front Biosci-Landmark"},{"issue":"11","key":"2364_CR204","doi-asserted-by":"crossref","first-page":"8545","DOI":"10.1021\/acs.jmedchem.4c00769","volume":"67","author":"O Mammoliti","year":"2024","unstructured":"Mammoliti O et al (2024) Discovery of GLPG3667, a selective ATP competitive tyrosine kinase 2 inhibitor for the treatment of autoimmune diseases. J Med Chem 67(11):8545\u20138568","journal-title":"J Med Chem"},{"issue":"5","key":"2364_CR205","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ajcn\/79.5.727","volume":"79","author":"C Manach","year":"2004","unstructured":"Manach C et al (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79(5):727\u2013747","journal-title":"Am J Clin Nutr"},{"key":"2364_CR206","doi-asserted-by":"crossref","unstructured":"Maramaldi, G., et al., Soothing and anti-itch effect of quercetin phytosome in human subjects: a single-blind study. Clinical, cosmetic and investigational dermatology, 2016: p. 55\u201362.","DOI":"10.2147\/CCID.S98890"},{"issue":"3","key":"2364_CR207","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/pro.321","volume":"19","author":"DJ Marcotte","year":"2010","unstructured":"Marcotte DJ et al (2010) Structures of human Bruton\u2019s tyrosine kinase in active and inactive conformations suggest a mechanism of activation for TEC family kinases. Protein Sci 19(3):429\u2013439","journal-title":"Protein Sci"},{"key":"2364_CR208","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.70263","author":"M Masson Regnault","year":"2025","unstructured":"Masson Regnault M et al (2025) French guidelines on systemic treatments for moderate\u2010to\u2010severe psoriasis in adults: update 2025. J Eur Acad Dermatol Venereol. https:\/\/doi.org\/10.1111\/jdv.70263","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"2364_CR209","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/0006-291X(92)90792-J","volume":"186","author":"WF Matter","year":"1992","unstructured":"Matter WF, Brown RF, Vlahos CJ (1992) The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs. Biochem Biophys Res Commun 186(2):624\u2013631","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2364_CR210","volume":"2013","author":"A Mavropoulos","year":"2013","unstructured":"Mavropoulos A et al (2013) The role of p38 MAPK in the aetiopathogenesis of psoriasis and psoriatic arthritis. J Immunol Res 2013(1):569751","journal-title":"J Immunol Res"},{"issue":"1","key":"2364_CR211","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaad.2020.04.139","volume":"84","author":"S Mehrmal","year":"2021","unstructured":"Mehrmal S et al (2021) The global, regional, and national burden of psoriasis in 195 countries and territories, 1990 to 2017: a systematic analysis from the Global Burden of Disease Study 2017. J Am Acad Dermatol 84(1):46\u201352","journal-title":"J Am Acad Dermatol"},{"issue":"13","key":"2364_CR212","doi-asserted-by":"crossref","first-page":"9238","DOI":"10.1021\/acs.jmedchem.1c00475","volume":"64","author":"FA Meijer","year":"2021","unstructured":"Meijer FA et al (2021) Structure\u2013activity relationship studies of trisubstituted isoxazoles as selective allosteric ligands for the retinoic-acid-receptor-related orphan receptor \u03b3t. J Med Chem 64(13):9238\u20139258","journal-title":"J Med Chem"},{"issue":"2","key":"2364_CR213","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s13555-021-00483-2","volume":"11","author":"A Menter","year":"2021","unstructured":"Menter A et al (2021) Interleukin-17 and interleukin-23: a narrative review of mechanisms of action in psoriasis and associated comorbidities. Dermatol Ther 11(2):385\u2013400","journal-title":"Dermatol Ther"},{"issue":"10","key":"2364_CR214","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.3390\/cells10102636","volume":"10","author":"L Mercurio","year":"2021","unstructured":"Mercurio L et al (2021a) PI3K\u03b4 sustains keratinocyte hyperproliferation and epithelial inflammation: implications for a topically druggable target in psoriasis. Cells 10(10):2636","journal-title":"Cells"},{"key":"2364_CR215","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.665647","volume":"8","author":"L Mercurio","year":"2021","unstructured":"Mercurio L, Albanesi C, Madonna S (2021b) Recent updates on the involvement of PI3K\/AKT\/mTOR molecular cascade in the pathogenesis of hyperproliferative skin disorders. Front Med 8:665647","journal-title":"Front Med"},{"issue":"12","key":"2364_CR216","doi-asserted-by":"crossref","first-page":"10012","DOI":"10.1021\/acs.jmedchem.4c00197","volume":"67","author":"Y Miao","year":"2024","unstructured":"Miao Y et al (2024) Functional and structural characterization of clinical-stage janus kinase 2 inhibitors identifies determinants for drug selectivity. J Med Chem 67(12):10012\u201310024","journal-title":"J Med Chem"},{"issue":"3","key":"2364_CR217","doi-asserted-by":"crossref","first-page":"1","DOI":"10.35702\/Derm.10038","volume":"5","author":"R Misra","year":"2025","unstructured":"Misra R et al (2025) JAK\/STAT pathway in psoriasis and psoriatic arthritis: insights into inflammation and tissue remodeling. Dermis 5(3):1\u201312","journal-title":"Dermis"},{"key":"2364_CR218","volume":"150","author":"S Mitra","year":"2022","unstructured":"Mitra S et al (2022) Prospective multifunctional roles and pharmacological potential of dietary flavonoid narirutin. Biomed Pharmacother 150:112932","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"2364_CR219","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/molecules21050623","volume":"21","author":"J Mlcek","year":"2016","unstructured":"Mlcek J et al (2016) Quercetin and its anti-allergic immune response. Molecules 21(5):623","journal-title":"Molecules"},{"issue":"1","key":"2364_CR220","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1600-065X.2008.00741.x","volume":"228","author":"AJ Mohamed","year":"2009","unstructured":"Mohamed AJ et al (2009) Bruton\u2019s tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain. Immunol Rev 228(1):58\u201373","journal-title":"Immunol Rev"},{"key":"2364_CR221","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7897263","author":"M Morelli","year":"2018","unstructured":"Morelli M et al (2018) Selective immunomodulation of inflammatory pathways in keratinocytes by the Janus kinase (JAK) inhibitor tofacitinib: implications for the employment of JAK\u2010targeting drugs in psoriasis. J Immunol Res. https:\/\/doi.org\/10.1155\/2018\/7897263","journal-title":"J Immunol Res"},{"issue":"1","key":"2364_CR222","doi-asserted-by":"publisher","first-page":"10633","DOI":"10.1038\/s41598-017-10410-1","volume":"7","author":"RA Morgan","year":"2017","unstructured":"Morgan RA et al (2017) Carbonyl reductase 1 catalyzes 20\u03b2-reduction of glucocorticoids, modulating receptor activation and metabolic complications of obesity. Sci Rep 7(1):10633","journal-title":"Sci Rep"},{"key":"2364_CR223","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/B978-0-12-809593-5.00002-1","volume-title":"Discovery and development of neuroprotective agents from natural products","author":"M Morissette","year":"2018","unstructured":"Morissette M, Litim N, Di Paolo T (2018) Natural phytoestrogens: a class of promising neuroprotective agents for Parkinson disease. Discovery and development of neuroprotective agents from natural products. Elsevier, pp 9\u201361"},{"key":"2364_CR224","unstructured":"Mustafa, A.M., et al., Targeting psoriatic inflammation with natural compounds: mechanistic insights and therapeutic promise. Inflammopharmacology, 2025: p. 1\u201328."},{"issue":"1","key":"2364_CR225","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00403-017-1792-6","volume":"310","author":"HR Nada","year":"2018","unstructured":"Nada HR et al (2018) Expression of Janus kinase 1 in vitiligo & psoriasis before and after narrow band UVB: a case\u2013control study. Arch Dermatol Res 310(1):39\u201346","journal-title":"Arch Dermatol Res"},{"key":"2364_CR226","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106215","volume":"80","author":"A Nadeem","year":"2020","unstructured":"Nadeem A et al (2020) Bruton\u2019s tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23\/IL-17A in innate immune cells. Int Immunopharmacol 80:106215","journal-title":"Int Immunopharmacol"},{"key":"2364_CR227","doi-asserted-by":"crossref","unstructured":"Naeem Sallam, M.A.E., et al., Efficacy and Safety of Biologic Therapies for Treatment of Psoriasis: A Systematic Review and Observational Meta-Analysis. QJM: An International Journal of Medicine, 2024. 117(Supplement_2).","DOI":"10.1093\/qjmed\/hcae175.214"},{"issue":"1","key":"2364_CR228","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.1600-0749.2003.00113.x","volume":"17","author":"H Nagata","year":"2004","unstructured":"Nagata H et al (2004) Quercetin enhances melanogenesis by increasing the activity and synthesis of tyrosinase in human melanoma cells and in normal human melanocytes. Pigment Cell Res 17(1):66\u201373","journal-title":"Pigment Cell Res"},{"issue":"1","key":"2364_CR229","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10286020.2018.1492565","volume":"22","author":"B Nageen","year":"2020","unstructured":"Nageen B et al (2020) Eupatilin: a natural pharmacologically active flavone compound with its wide range applications. J Asian Nat Prod Res 22(1):1\u201316","journal-title":"J Asian Nat Prod Res"},{"issue":"3","key":"2364_CR230","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.molonc.2012.10.013","volume":"7","author":"S Nam","year":"2013","unstructured":"Nam S et al (2013) Dual inhibition of Janus and Src family kinases by novel indirubin derivative blocks constitutively-activated Stat3 signaling associated with apoptosis of human pancreatic cancer cells. Mol Oncol 7(3):369\u2013378","journal-title":"Mol Oncol"},{"issue":"2","key":"2364_CR231","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.fitote.2009.08.006","volume":"81","author":"L Navarro-N\u00fa\u00f1ez","year":"2010","unstructured":"Navarro-N\u00fa\u00f1ez L et al (2010) Effect of quercetin on platelet spreading on collagen and fibrinogen and on multiple platelet kinases. Fitoterapia 81(2):75\u201380","journal-title":"Fitoterapia"},{"issue":"1","key":"2364_CR232","volume":"2014","author":"A Neve","year":"2014","unstructured":"Neve A et al (2014) Extracellular matrix modulates angiogenesis in physiological and pathological conditions. BioMed Res Int 2014(1):756078","journal-title":"BioMed Res Int"},{"issue":"11","key":"2364_CR233","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1248\/bpb.b15-00331","volume":"38","author":"W Ning","year":"2015","unstructured":"Ning W et al (2015) Epigallocatechin-3-gallate (EGCG) suppresses the trafficking of lymphocytes to epidermal melanocytes via inhibition of JAK2: its implication for vitiligo treatment. Biol Pharm Bull (Tokyo) 38(11):1700\u20131706","journal-title":"Biol Pharm Bull (Tokyo)"},{"key":"2364_CR234","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O'Boyle","year":"2011","unstructured":"O\u2019Boyle NM et al (2011) Open Babel: an open chemical toolbox. J Cheminform 3:1\u201314","journal-title":"J Cheminform"},{"issue":"1","key":"2364_CR235","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1021\/ci050283k","volume":"46","author":"A Oda","year":"2006","unstructured":"Oda A et al (2006) Comparison of consensus scoring strategies for evaluating computational models of protein\u2212 ligand complexes. J Chem Inf Model 46(1):380\u2013391","journal-title":"J Chem Inf Model"},{"issue":"2","key":"2364_CR236","first-page":"275","volume":"16","author":"T Okamoto","year":"2005","unstructured":"Okamoto T (2005) Safety of quercetin for clinical application. Int J Mol Med 16(2):275\u2013278","journal-title":"Int J Mol Med"},{"key":"2364_CR237","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tox.2017.02.012","volume":"381","author":"J \u00d6stlund","year":"2017","unstructured":"\u00d6stlund J, Zlabek V, Zamaratskaia G (2017) In vitro inhibition of human CYP2E1 and CYP3A by quercetin and myricetin in hepatic microsomes is not gender dependent. Toxicology 381:10\u201318","journal-title":"Toxicology"},{"key":"2364_CR238","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-3-319-41334-1_10","volume-title":"Anti-inflammatory nutraceuticals and chronic diseases","author":"HC Pal","year":"2016","unstructured":"Pal HC, Pearlman RL, Afaq F (2016) Fisetin and its role in chronic diseases. Anti-inflammatory nutraceuticals and chronic diseases. pp 213\u2013244"},{"issue":"1","key":"2364_CR239","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0779-z","volume":"17","author":"S Pal Singh","year":"2018","unstructured":"Pal Singh S, Dammeijer F, Hendriks RW (2018) Role of Bruton\u2019s tyrosine kinase in B cells and malignancies. Mol Cancer 17(1):57","journal-title":"Mol Cancer"},{"issue":"1","key":"2364_CR240","doi-asserted-by":"publisher","first-page":"5142","DOI":"10.1038\/s41598-019-41594-3","volume":"9","author":"K Palacio-Rodr\u00edguez","year":"2019","unstructured":"Palacio-Rodr\u00edguez K et al (2019) Exponential consensus ranking improves the outcome in docking and receptor ensemble docking. Sci Rep 9(1):5142","journal-title":"Sci Rep"},{"issue":"7","key":"2364_CR241","volume":"21","author":"Y Pan","year":"2026","unstructured":"Pan Y, Mei M, Liu Y (2026) The potential of quercetin and its derivatives in the treatment of psoriasis: a systematic review. Nat Prod Commun 21(7):1934578X261470324","journal-title":"Nat Prod Commun"},{"issue":"10","key":"2364_CR242","doi-asserted-by":"publisher","first-page":"4836","DOI":"10.1007\/s00044-013-0503-x","volume":"22","author":"AK Pandey","year":"2013","unstructured":"Pandey AK et al (2013) Neuroprotective effects of quercetin in chemical hypoxia: in silico evaluation of the hypothesis exploring PKC inhibition-mediated pharmacotherapy. Med Chem Res 22(10):4836\u20134841","journal-title":"Med Chem Res"},{"key":"2364_CR243","unstructured":"Pandey, P., et al., A mechanistic review of the pharmacological potential of narirutin: A dietary flavonoid. Naunyn-Schmiedeberg's Archives of Pharmacology, 2024: p. 1\u201313."},{"issue":"6","key":"2364_CR244","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1172\/JCI61862","volume":"122","author":"S Pantelyushin","year":"2012","unstructured":"Pantelyushin S et al (2012) Ror\u03b3t+ innate lymphocytes and \u03b3\u03b4 T cells initiate psoriasiform plaque formation in mice. J Clin Invest 122(6):2252\u20132256","journal-title":"J Clin Invest"},{"issue":"1","key":"2364_CR245","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41467-022-28164-4","volume":"13","author":"T Pantsar","year":"2022","unstructured":"Pantsar T et al (2022) Decisive role of water and protein dynamics in residence time of p38\u03b1 MAP kinase inhibitors. Nat Commun 13(1):569","journal-title":"Nat Commun"},{"issue":"6","key":"2364_CR246","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/bjd.14403","volume":"174","author":"K Papp","year":"2016","unstructured":"Papp K et al (2016) A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1\/JAK2 inhibitor, in patients with moderate-to-severe psoriasis. Br J Dermatol 174(6):1266\u20131276","journal-title":"Br J Dermatol"},{"issue":"12","key":"2364_CR247","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","volume":"52","author":"M Parrinello","year":"1981","unstructured":"Parrinello M, Rahman A (1981) Polymorphic transitions in single crystals: a new molecular dynamics method. J Appl Phys 52(12):7182\u20137190","journal-title":"J Appl Phys"},{"issue":"3","key":"2364_CR248","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3233\/HAB-210447","volume":"29","author":"V Patel","year":"2021","unstructured":"Patel V et al (2021) Immunogenicity of biologics used in the treatment of moderate to severe psoriasis. Hum Antibodies 29(3):171\u2013178","journal-title":"Hum Antibodies"},{"issue":"11","key":"2364_CR249","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1021\/bi027308i","volume":"42","author":"TA Pauly","year":"2003","unstructured":"Pauly TA et al (2003) Specificity determinants of human cathepsin S revealed by crystal structures of complexes. Biochemistry 42(11):3203\u20133213","journal-title":"Biochemistry"},{"issue":"43","key":"2364_CR250","doi-asserted-by":"crossref","first-page":"14073","DOI":"10.1021\/acs.jafc.2c05724","volume":"70","author":"H Peng","year":"2022","unstructured":"Peng H, Shahidi F (2022) Quercetin fatty acid monoesters (C2: 0\u2013C18: 0): enzymatic preparation and antioxidant activity. J Agric Food Chem 70(43):14073\u201314083","journal-title":"J Agric Food Chem"},{"issue":"1","key":"2364_CR251","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s13075-015-0771-6","volume":"17","author":"M Perez-Aso","year":"2015","unstructured":"Perez-Aso M et al (2015) Apremilast, a novel phosphodiesterase 4 (PDE4) inhibitor, regulates inflammation through multiple cAMP downstream effectors. Arthritis Res Ther 17(1):249","journal-title":"Arthritis Res Ther"},{"issue":"13","key":"2364_CR252","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF et al (2004) UCSF Chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem 25(13):1605\u20131612","journal-title":"J Comput Chem"},{"issue":"17","key":"2364_CR253","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.3390\/ijms20174293","volume":"20","author":"TN Pham","year":"2019","unstructured":"Pham TN et al (2019) Quercetin enhances the anti-tumor effects of BET inhibitors by suppressing hnRNPA1. Int J Mol Sci 20(17):4293","journal-title":"Int J Mol Sci"},{"issue":"31","key":"2364_CR254","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.2174\/0929867325666180713150626","volume":"26","author":"N Poler\u00e0","year":"2019","unstructured":"Poler\u00e0 N et al (2019) Quercetin and its natural sources in wound healing management. Curr Med Chem 26(31):5825\u20135848","journal-title":"Curr Med Chem"},{"key":"2364_CR255","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.6477","volume":"7","author":"A Poulev","year":"2019","unstructured":"Poulev A et al (2019) Tricin levels and expression of flavonoid biosynthetic genes in developing grains of purple and brown pericarp rice. PeerJ 7:e6477","journal-title":"PeerJ"},{"issue":"9","key":"2364_CR256","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s10822-019-00227-7","volume":"33","author":"J Preto","year":"2019","unstructured":"Preto J, Gentile F (2019) Assessing and improving the performance of consensus docking strategies using the DockBox package. J Comput Aided Mol des 33(9):817\u2013829","journal-title":"J Comput Aided Mol des"},{"key":"2364_CR257","doi-asserted-by":"crossref","unstructured":"Puli, M., et al., Beyond Pose Accuracy: Reproducibility-Oriented Framework For Interpreting Web-Based Molecular Docking Outputs Using Decoupled Localization and Pose Fidelity Metrics. 2026.","DOI":"10.21203\/rs.3.rs-8908837\/v1"},{"issue":"1","key":"2364_CR258","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s40001-023-01144-0","volume":"28","author":"Y Qu","year":"2023","unstructured":"Qu Y et al (2023) Transcriptional regulation on effector T cells in the pathogenesis of psoriasis. Eur J Med Res 28(1):182","journal-title":"Eur J Med Res"},{"issue":"W1","key":"2364_CR259","doi-asserted-by":"crossref","first-page":"W591","DOI":"10.1093\/nar\/gkaa367","volume":"48","author":"T Ra\u010dek","year":"2020","unstructured":"Ra\u010dek T et al (2020) Atomic charge calculator II: web-based tool for the calculation of partial atomic charges. Nucleic Acids Res 48(W1):W591\u2013W596","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2364_CR260","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10787-024-01602-z","volume":"33","author":"A Radu","year":"2025","unstructured":"Radu A et al (2025) Naturally derived bioactive compounds as precision modulators of immune and inflammatory mechanisms in psoriatic conditions. Inflammopharmacology 33(2):527\u2013549","journal-title":"Inflammopharmacology"},{"issue":"3","key":"2364_CR261","doi-asserted-by":"crossref","first-page":"170","DOI":"10.7861\/clinmed.2021-0257","volume":"21","author":"A Raharja","year":"2021","unstructured":"Raharja A, Mahil SK, Barker JN (2021) Psoriasis: a brief overview. Clin Med 21(3):170\u2013173","journal-title":"Clin Med"},{"issue":"2\u20133","key":"2364_CR262","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/08820139.2020.1726381","volume":"50","author":"M Rahmati","year":"2021","unstructured":"Rahmati M et al (2021) Modulation of Th17 proliferation and IL-17A gene expression by acetylated form of apigenin in patients with multiple sclerosis. Immunol Invest 50(2\u20133):216\u2013229","journal-title":"Immunol Invest"},{"issue":"1","key":"2364_CR263","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrd2897","volume":"9","author":"L Rajendran","year":"2010","unstructured":"Rajendran L, Kn\u00f6lker H-J, Simons K (2010) Subcellular targeting strategies for drug design and delivery. Nat Rev Drug Discov 9(1):29\u201342","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"2364_CR264","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2174\/2589977514666220509201804","volume":"14","author":"V Ramachandran","year":"2022","unstructured":"Ramachandran V, Tiwari R, Tiwari G (2022) Biochanin-A: a bioactive natural product with versatile therapeutic perspectives. Current Drug Research Reviews Formerly: Current Drug Abuse Reviews 14(3):225\u2013238","journal-title":"Current Drug Research Reviews Formerly: Current Drug Abuse Reviews"},{"issue":"7","key":"2364_CR265","doi-asserted-by":"crossref","first-page":"593","DOI":"10.63682\/jns.v14i7.5976","volume":"14","author":"NGR Rao","year":"2025","unstructured":"Rao NGR et al (2025) Development of a novel quercetin phytosome-based topical hydrogel for anti-inflammatory and antioxidant effects in psoriasis. J Neonatal Surg 14(7):593\u2013601","journal-title":"J Neonatal Surg"},{"key":"2364_CR266","doi-asserted-by":"crossref","unstructured":"Rasul, A., et al., Pinocembrin: a novel natural compound with versatile pharmacological and biological activities. BioMed research international, 2013. 2013.","DOI":"10.1155\/2013\/379850"},{"issue":"1","key":"2364_CR267","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8864","volume":"6","author":"VB Reddy","year":"2015","unstructured":"Reddy VB et al (2015) Redefining the concept of protease-activated receptors: cathepsin S evokes itch via activation of Mrgprs. Nat Commun 6(1):7864","journal-title":"Nat Commun"},{"key":"2364_CR268","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/B978-0-12-824356-5.00002-3","volume-title":"The Role of Phytonutrients in Metabolic Disorders","author":"A Riaz","year":"2022","unstructured":"Riaz A et al (2022) Cancer metabolism regulation by phytonutrients. The Role of Phytonutrients in Metabolic Disorders. Elsevier, pp 237\u2013290"},{"key":"2364_CR269","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.662223","volume":"12","author":"GE Ringheim","year":"2021","unstructured":"Ringheim GE, Wampole M, Oberoi K (2021) Bruton\u2019s tyrosine kinase (BTK) inhibitors and autoimmune diseases: making sense of BTK inhibitor specificity profiles and recent clinical trial successes and failures. Front Immunol 12:662223","journal-title":"Front Immunol"},{"issue":"2","key":"2364_CR270","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s13318-018-0517-3","volume":"44","author":"A Riva","year":"2019","unstructured":"Riva A et al (2019) Improved oral absorption of quercetin from quercetin phytosome\u00ae, a new delivery system based on food grade lecithin. Eur J Drug Metab Pharmacokinet 44(2):169\u2013177","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"10","key":"2364_CR271","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.3390\/jcm11102807","volume":"11","author":"E Robak","year":"2022","unstructured":"Robak E, Robak T (2022) Bruton\u2019s kinase inhibitors for the treatment of immunological diseases: current status and perspectives. J Clin Med 11(10):2807","journal-title":"J Clin Med"},{"issue":"9","key":"2364_CR272","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.4049\/jimmunol.1103173","volume":"189","author":"A Roller","year":"2012","unstructured":"Roller A et al (2012) Blockade of phosphatidylinositol 3-kinase (PI3K) \u03b4 or PI3K\u03b3 reduces IL-17 and ameliorates imiquimod-induced psoriasis-like dermatitis. J Immunol 189(9):4612\u20134620","journal-title":"J Immunol"},{"key":"2364_CR273","unstructured":"Rose, P.W., et al., The RCSB protein data bank: integrative view of protein, gene and 3D structural information. Nucleic acids research, 2016: p. gkw1000."},{"issue":"12","key":"2364_CR274","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.3390\/cells12121671","volume":"12","author":"T Roy","year":"2023","unstructured":"Roy T et al (2023) The PI3K-Akt-mTOR and associated signaling pathways as molecular drivers of immune-mediated inflammatory skin diseases: update on therapeutic strategy using natural and synthetic compounds. Cells 12(12):1671","journal-title":"Cells"},{"key":"2364_CR275","first-page":"185","volume-title":"Advances in nutrition and cancer","author":"GL Russo","year":"2013","unstructured":"Russo GL et al (2013) Quercetin: a pleiotropic kinase inhibitor against cancer. Advances in nutrition and cancer. pp 185\u2013205"},{"key":"2364_CR276","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.70780","volume":"11","author":"A Rutz","year":"2022","unstructured":"Rutz A et al (2022) The LOTUS initiative for open knowledge management in natural products research. Elife 11:e70780","journal-title":"Elife"},{"key":"2364_CR277","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155897","volume":"156","author":"KL Sachen","year":"2022","unstructured":"Sachen KL, Greving CNA, Towne JE (2022) Role of IL-36 cytokines in psoriasis and other inflammatory skin conditions. Cytokine 156:155897","journal-title":"Cytokine"},{"key":"2364_CR278","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.matbio.2022.02.003","volume":"107","author":"J Sage","year":"2022","unstructured":"Sage J et al (2022) Modulation of the expression and activity of cathepsin S in reconstructed human skin by neohesperidin dihydrochalcone. Matrix Biol 107:97\u2013112","journal-title":"Matrix Biol"},{"issue":"4","key":"2364_CR279","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jaci.2019.06.019","volume":"144","author":"K Sakurai","year":"2019","unstructured":"Sakurai K et al (2019) Cutaneous p38 mitogen-activated protein kinase activation triggers psoriatic dermatitis. J Allergy Clin Immunol 144(4):1036\u20131049","journal-title":"J Allergy Clin Immunol"},{"key":"2364_CR280","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1158633","volume":"10","author":"NG Sannappa Gowda","year":"2023","unstructured":"Sannappa Gowda NG et al (2023) Quercetin activates vitamin D receptor and ameliorates breast cancer induced hepatic inflammation and fibrosis. Front Nutr 10:1158633","journal-title":"Front Nutr"},{"key":"2364_CR281","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/B978-0-323-89779-2.00016-8","volume-title":"Nutraceuticals and health care","author":"L Sarao","year":"2022","unstructured":"Sarao L et al (2022) Genistein and daidzein. Nutraceuticals and health care. Elsevier, pp 331\u2013341"},{"key":"2364_CR282","doi-asserted-by":"crossref","unstructured":"Sato, S. and Y. Mukai, Modulation of chronic inflammation by quercetin: The beneficial effects on obesity. Journal of inflammation research, 2020: p. 421\u2013431.","DOI":"10.2147\/JIR.S228361"},{"issue":"2","key":"2364_CR283","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000345210","volume":"26","author":"S Scalia","year":"2013","unstructured":"Scalia S et al (2013) Comparative evaluation of the effect of permeation enhancers, lipid nanoparticles and colloidal silica on in vivo human skin penetration of quercetin. Skin Pharmacol Physiol 26(2):57\u201367","journal-title":"Skin Pharmacol Physiol"},{"issue":"56","key":"2364_CR284","doi-asserted-by":"crossref","first-page":"35383","DOI":"10.1039\/D1RA05785E","volume":"11","author":"V Scardino","year":"2021","unstructured":"Scardino V, Bollini M, Cavasotto CN (2021) Combination of pose and rank consensus in docking-based virtual screening: the best of both worlds. RSC Adv 11(56):35383\u201335391","journal-title":"RSC Adv"},{"issue":"20","key":"2364_CR285","doi-asserted-by":"crossref","first-page":"11801","DOI":"10.1021\/acs.jmedchem.0c00949","volume":"63","author":"M Schade","year":"2020","unstructured":"Schade M et al (2020) Highly selective sub-nanomolar cathepsin S inhibitors by merging fragment binders with nitrile inhibitors. J Med Chem 63(20):11801\u201311808","journal-title":"J Med Chem"},{"issue":"6","key":"2364_CR286","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jaad.2012.10.064","volume":"68","author":"PH Schafer","year":"2013","unstructured":"Schafer PH, Day RM (2013) Novel systemic drugs for psoriasis: mechanism of action for apremilast, a specific inhibitor of PDE4. J Am Acad Dermatol 68(6):1041\u20131042","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"2364_CR287","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.cellsig.2014.05.014","volume":"26","author":"P Schafer","year":"2014","unstructured":"Schafer P et al (2014) Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity. Cell Signal 26(9):2016\u20132029","journal-title":"Cell Signal"},{"issue":"7","key":"2364_CR288","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cellsig.2016.01.007","volume":"28","author":"PH Schafer","year":"2016","unstructured":"Schafer PH et al (2016) Phosphodiesterase 4 in inflammatory diseases: effects of apremilast in psoriatic blood and in dermal myofibroblasts through the PDE4\/CD271 complex. Cell Signal 28(7):753\u2013763","journal-title":"Cell Signal"},{"issue":"1","key":"2364_CR289","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9833","volume":"6","author":"M Scheepstra","year":"2015","unstructured":"Scheepstra M et al (2015) Identification of an allosteric binding site for ROR\u03b3t inhibition. Nat Commun 6(1):8833","journal-title":"Nat Commun"},{"issue":"8","key":"2364_CR290","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1111\/j.1600-0625.2009.00990.x","volume":"19","author":"A Sch\u00f6nefu\u00df","year":"2010","unstructured":"Sch\u00f6nefu\u00df A et al (2010) Upregulation of cathepsin S in psoriatic keratinocytes. Exp Dermatol 19(8):e80\u2013e88","journal-title":"Exp Dermatol"},{"issue":"12","key":"2364_CR291","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nrd.2017.201","volume":"16","author":"DM Schwartz","year":"2017","unstructured":"Schwartz DM et al (2017) JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. Nat Rev Drug Discov 16(12):843\u2013862","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"2364_CR292","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2174\/1573409912666151124233847","volume":"11","author":"P Sharma","year":"2015","unstructured":"Sharma P et al (2015) Water molecules increases binding affinity of natural PI3K\u03b3 inhibitors against cancer. Curr Comput Aided Drug des 11(4):304\u2013320","journal-title":"Curr Comput Aided Drug des"},{"issue":"5","key":"2364_CR293","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14051001","volume":"14","author":"AM Shawky","year":"2022","unstructured":"Shawky AM et al (2022) A comprehensive overview of globally approved JAK inhibitors. Pharmaceutics 14(5):1001","journal-title":"Pharmaceutics"},{"key":"2364_CR294","volume":"12","author":"P Shen","year":"2021","unstructured":"Shen P et al (2021) Potential implications of quercetin in autoimmune diseases. Front Immunol 12:689044","journal-title":"Front Immunol"},{"key":"2364_CR295","doi-asserted-by":"crossref","unstructured":"Sheppard, D., R. Terrell, and G. Henkelman, Optimization methods for finding minimum energy paths. The Journal of chemical physics, 2008. 128(13).","DOI":"10.1063\/1.2841941"},{"issue":"1","key":"2364_CR296","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5530\/ijper.56.1.33","volume":"56","author":"P Shetti","year":"2022","unstructured":"Shetti P, Jalalpure SS (2022) Optimization of a validated UV-spectrophotometric methodology for assessment of apigenin in bulk powder. Indian J Pharmac Educ Res 56(1):281\u2013286","journal-title":"Indian J Pharmac Educ Res"},{"issue":"1","key":"2364_CR297","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejphar.2010.06.026","volume":"643","author":"C-H Shih","year":"2010","unstructured":"Shih C-H et al (2010) Genistein, a competitive PDE1\u20134 inhibitor, may bind on high-affinity rolipram binding sites of brain cell membranes and then induce gastrointestinal adverse effects. Eur J Pharmacol 643(1):113\u2013120","journal-title":"Eur J Pharmacol"},{"key":"2364_CR298","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20215262","author":"EJ Shin","year":"2019","unstructured":"Shin EJ et al (2019a) Quercetin directly targets JAK2 and PKC\u03b4 and prevents UV-induced photoaging in human skin. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20215262","journal-title":"Int J Mol Sci"},{"issue":"21","key":"2364_CR299","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.3390\/ijms20215262","volume":"20","author":"EJ Shin","year":"2019","unstructured":"Shin EJ et al (2019b) Quercetin directly targets JAK2 and PKC\u03b4 and prevents UV-induced photoaging in human skin. Int J Mol Sci 20(21):5262","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2364_CR300","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/0929867327666191230104958","volume":"28","author":"H Si","year":"2021","unstructured":"Si H, Lai C-Q, Liu D (2021) Dietary epicatechin, a novel anti-aging bioactive small molecule. Curr Med Chem 28(1):3\u201318","journal-title":"Curr Med Chem"},{"issue":"2","key":"2364_CR301","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","volume":"66","author":"I Sieminska","year":"2024","unstructured":"Sieminska I, Pieniawska M, Grzywa TM (2024b) The immunology of psoriasis\u2014current concepts in pathogenesis. Clin Rev Allergy Immunol 66(2):164\u2013191","journal-title":"Clin Rev Allergy Immunol"},{"key":"2364_CR302","doi-asserted-by":"crossref","unstructured":"Sieminska, I., M. Pieniawska, and T.M. Grzywa, The Immunology of Psoriasis\u2014Current Concepts in Pathogenesis. Clinical Reviews in Allergy & Immunology, 2024: p. 1\u201328.","DOI":"10.1007\/s12016-024-08991-7"},{"issue":"3","key":"2364_CR303","doi-asserted-by":"crossref","first-page":"AB150","DOI":"10.1016\/j.jaad.2021.06.614","volume":"85","author":"B Sigurgeirsson","year":"2021","unstructured":"Sigurgeirsson B et al (2021) 27519 Efficacy, pharmacokinetics, and tolerability of subcutaneous secukinumab injections with 2 mL prefilled syringes (300 mg) in adult subjects with moderate to severe plaque psoriasis. J Am Acad Dermatol 85(3):AB150","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2364_CR304","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.gendis.2019.09.015","volume":"7","author":"A Singh","year":"2020","unstructured":"Singh A et al (2020) An updated review on activated PI3 kinase delta syndrome (APDS). Genes Dis 7(1):67\u201374","journal-title":"Genes Dis"},{"issue":"7","key":"2364_CR305","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1021\/acsomega.1c06715","volume":"7","author":"MF Sk","year":"2022","unstructured":"Sk MF et al (2022) Unraveling the molecular mechanism of recognition of selected next-generation antirheumatoid arthritis inhibitors by Janus kinase 1. ACS Omega 7(7):6195\u20136209","journal-title":"ACS Omega"},{"issue":"9","key":"2364_CR306","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1172\/JCI35636","volume":"118","author":"H Skvara","year":"2008","unstructured":"Skvara H et al (2008) The PKC inhibitor AEB071 may be a therapeutic option for psoriasis. J Clin Invest 118(9):3151\u20133159","journal-title":"J Clin Invest"},{"issue":"19","key":"2364_CR307","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.3390\/jcm10194307","volume":"10","author":"S S\u0142uczanowska-G\u0142\u0105bowska","year":"2021","unstructured":"S\u0142uczanowska-G\u0142\u0105bowska S et al (2021) Role of Janus kinase inhibitors in therapy of psoriasis. J Clin Med 10(19):4307","journal-title":"J Clin Med"},{"issue":"7564","key":"2364_CR308","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/bmj.333.7564.380","volume":"333","author":"CH Smith","year":"2006","unstructured":"Smith CH, Barker J (2006) Psoriasis and its management. BMJ 333(7564):380\u2013384","journal-title":"BMJ"},{"key":"2364_CR309","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/B978-0-12-821277-6.00007-6","volume-title":"Discovery and development of anti-breast cancer agents from natural products","author":"D \u015e\u00f6hreto\u011flu","year":"2021","unstructured":"\u015e\u00f6hreto\u011flu D et al (2021) Flavonoids as inducers of apoptosis and autophagy in breast cancer. Discovery and development of anti-breast cancer agents from natural products. Elsevier, pp 147\u2013196"},{"key":"2364_CR310","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153802","volume":"93","author":"X Song","year":"2021","unstructured":"Song X et al (2021) Myricetin exhibit selective anti-lymphoma activity by targeting BTK and is effective via oral administration in vivo. Phytomedicine 93:153802","journal-title":"Phytomedicine"},{"key":"2364_CR311","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102614","volume":"118","author":"AK Srivastava","year":"2021","unstructured":"Srivastava AK et al (2021) Insights into interplay of immunopathophysiological events and molecular mechanistic cascades in psoriasis and its associated comorbidities. J Autoimmun 118:102614","journal-title":"J Autoimmun"},{"issue":"4","key":"2364_CR312","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00044-023-03037-7","volume":"32","author":"S Srivastava","year":"2023","unstructured":"Srivastava S, Mathew J, Pandey A (2023) Baicalein\u2014a review on its molecular mechanism against breast cancer and delivery strategies. Med Chem Res 32(4):643\u2013658","journal-title":"Med Chem Res"},{"key":"2364_CR313","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1419110","volume":"15","author":"SM Stefan","year":"2024","unstructured":"Stefan SM, Rafehi M (2024) Medicinal polypharmacology-a scientific glossary of terminology and concepts. Front Pharmacol 15:1419110","journal-title":"Front Pharmacol"},{"issue":"5","key":"2364_CR314","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/bjd.12517","volume":"169","author":"B Strober","year":"2013","unstructured":"Strober B et al (2013) Effect of tofacitinib, a Janus kinase inhibitor, on haematological parameters during 12 weeks of psoriasis treatment. Br J Dermatol 169(5):992\u2013999","journal-title":"Br J Dermatol"},{"issue":"1","key":"2364_CR315","doi-asserted-by":"publisher","first-page":"15604","DOI":"10.1038\/s41598-017-10697-0","volume":"7","author":"MM Sultan","year":"2017","unstructured":"Sultan MM et al (2017) Millisecond dynamics of BTK reveal kinome-wide conformational plasticity within the apo kinase domain. Sci Rep 7(1):15604","journal-title":"Sci Rep"},{"issue":"4","key":"2364_CR316","volume":"23","author":"X Sun","year":"2024","unstructured":"Sun X et al (2024) Formation and clinical effects of anti-drug antibodies against biologics in psoriasis treatment: an analysis of current evidence. Autoimmun Rev 23(4):103530","journal-title":"Autoimmun Rev"},{"key":"2364_CR317","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2019.112066","volume":"166","author":"C Sunil","year":"2019","unstructured":"Sunil C, Xu B (2019) An insight into the health-promoting effects of taxifolin (dihydroquercetin). Phytochemistry 166:112066","journal-title":"Phytochemistry"},{"issue":"8","key":"2364_CR318","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1080\/07391102.2018.1475260","volume":"37","author":"D Suplatov","year":"2019","unstructured":"Suplatov D et al (2019) Human p38\u03b1 mitogen-activated protein kinase in the Asp168-Phe169-Gly170-in (DFG-in) state can bind allosteric inhibitor Doramapimod. J Biomol Struct Dyn 37(8):2049\u20132060","journal-title":"J Biomol Struct Dyn"},{"issue":"2","key":"2364_CR319","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1023\/B:HIJO.0000023388.51625.6c","volume":"35","author":"R Takeyama","year":"2004","unstructured":"Takeyama R et al (2004) Quercetin-induced melanogenesis in a reconstituted three-dimensional human epidermal model. J Mol Histol 35(2):157\u2013165","journal-title":"J Mol Histol"},{"issue":"8","key":"2364_CR320","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41419-020-02891-2","volume":"11","author":"J Tan","year":"2020","unstructured":"Tan J et al (2020) Small molecules targeting ROR\u03b3t inhibit autoimmune disease by suppressing Th17 cell differentiation. Cell Death Dis 11(8):697","journal-title":"Cell Death Dis"},{"key":"2364_CR321","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3389\/fimmu.2018.01210","volume":"9","author":"L Tang","year":"2018","unstructured":"Tang L et al (2018) Transcription factor retinoid-related orphan receptor \u03b3t: a promising target for the treatment of psoriasis. Front Immunol 9:1210","journal-title":"Front Immunol"},{"key":"2364_CR322","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s42358-024-00401-y","volume":"64","author":"GM Tavakoli","year":"2024","unstructured":"Tavakoli GM, Yazdanpanah N, Rezaei N (2024) Targeting Bruton\u2019s tyrosine kinase (BTK) as a signaling pathway in immune-mediated diseases: from molecular mechanisms to leading treatments. Adv Rheumatol 64:61","journal-title":"Adv Rheumatol"},{"issue":"11","key":"2364_CR323","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1021\/jm051197e","volume":"49","author":"R Thomsen","year":"2006","unstructured":"Thomsen R, Christensen MH (2006) MolDock: a new technique for high-accuracy molecular docking. J Med Chem 49(11):3315\u20133321","journal-title":"J Med Chem"},{"issue":"6","key":"2364_CR324","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13827","volume":"33","author":"J Torales","year":"2020","unstructured":"Torales J et al (2020) Psychodermatological mechanisms of psoriasis. Dermatol Ther 33(6):e13827","journal-title":"Dermatol Ther"},{"issue":"5","key":"2364_CR325","doi-asserted-by":"crossref","first-page":"L396","DOI":"10.1152\/ajplung.00125.2013","volume":"305","author":"EA Townsend","year":"2013","unstructured":"Townsend EA, Emala CW Sr. (2013) Quercetin acutely relaxes airway smooth muscle and potentiates \u03b2-agonist-induced relaxation via dual phosphodiesterase inhibition of PLC\u03b2 and PDE4. Am J Physiol Lung Cell Mol Physiol 305(5):L396-403","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"2364_CR326","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455\u2013461","journal-title":"J Comput Chem"},{"issue":"16","key":"2364_CR327","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jcim.4c00823","volume":"64","author":"WF Van Gunsteren","year":"2024","unstructured":"Van Gunsteren WF, Oostenbrink C (2024) Methods for classical-mechanical molecular simulation in chemistry: achievements, limitations, perspectives. J Chem Inf Model 64(16):6281\u20136304","journal-title":"J Chem Inf Model"},{"issue":"4","key":"2364_CR328","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrd.2018.26","volume":"17","author":"RA van Waterschoot","year":"2018","unstructured":"van Waterschoot RA et al (2018) Impact of target interactions on small-molecule drug disposition: an overlooked area. Nat Rev Drug Discovery 17(4):299\u2013299","journal-title":"Nat Rev Drug Discovery"},{"issue":"3","key":"2364_CR329","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ejpb.2008.01.012","volume":"69","author":"FT Vicentini","year":"2008","unstructured":"Vicentini FT et al (2008a) Quercetin in w\/o microemulsion: in vitro and in vivo skin penetration and efficacy against UVB-induced skin damages evaluated in vivo. Eur J Pharm Biopharm 69(3):948\u2013957","journal-title":"Eur J Pharm Biopharm"},{"key":"2364_CR330","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/B978-0-444-63749-9.00006-2","volume":"50","author":"A Vidal-Albalat","year":"2016","unstructured":"Vidal-Albalat A, Gonz\u00e1lez FV (2016) Natural products as cathepsin inhibitors. Stud Nat Prod Chem 50:179\u2013213","journal-title":"Stud Nat Prod Chem"},{"issue":"3","key":"2364_CR331","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bjp.2014.07.010","volume":"24","author":"A Vijayalakshmi","year":"2014","unstructured":"Vijayalakshmi A, Madhira G (2014) Anti-psoriatic activity of flavonoids from Cassia tora leaves using the rat ultraviolet B ray photodermatitis model. Rev Bras Farmacogn 24(3):322\u2013329","journal-title":"Rev Bras Farmacogn"},{"issue":"1","key":"2364_CR332","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1021\/jm501603h","volume":"58","author":"R Vijayan","year":"2015","unstructured":"Vijayan R et al (2015) Conformational analysis of the DFG-out kinase motif and biochemical profiling of structurally validated type II inhibitors. J Med Chem 58(1):466\u2013479","journal-title":"J Med Chem"},{"key":"2364_CR333","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e33342","author":"A Vollmannov\u00e1","year":"2024","unstructured":"Vollmannov\u00e1 A et al (2024) Quercetin as one of the most abundant represented biological valuable plant components with remarkable chemoprotective effects-a review. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33342","journal-title":"Heliyon"},{"issue":"2","key":"2364_CR334","volume":"2","author":"K Wadhwa","year":"2022","unstructured":"Wadhwa K et al (2022) New insights into quercetin nanoformulations for topical delivery. Phytomed plus 2(2):100257","journal-title":"Phytomed plus"},{"issue":"4","key":"2364_CR335","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1097-2765(05)00089-4","volume":"6","author":"EH Walker","year":"2000","unstructured":"Walker EH et al (2000) Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell 6(4):909\u2013919","journal-title":"Mol Cell"},{"issue":"2","key":"2364_CR336","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1042\/BJ20070970","volume":"408","author":"H Wang","year":"2007","unstructured":"Wang H et al (2007a) Structures of the four subfamilies of phosphodiesterase-4 provide insight into the selectivity of their inhibitors. Biochem J 408(2):193\u2013201","journal-title":"Biochem J"},{"issue":"2","key":"2364_CR337","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jmb.2007.05.060","volume":"371","author":"H Wang","year":"2007","unstructured":"Wang H, Robinson H, Ke H (2007b) The molecular basis for different recognition of substrates by phosphodiesterase families 4 and 10. J Mol Biol 371(2):302\u2013307","journal-title":"J Mol Biol"},{"key":"2364_CR338","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3997190","author":"G Wang","year":"2022","unstructured":"Wang G et al (2022) Pharmacological activity of quercetin: an updated review. Evid Based Complement Alternat Med. https:\/\/doi.org\/10.1155\/2022\/3997190","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"2364_CR339","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1186\/s12967-023-04443-6","volume":"21","author":"Z Wang","year":"2023","unstructured":"Wang Z et al (2023) Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation. J Transl Med 21(1):579","journal-title":"J Transl Med"},{"key":"2364_CR340","volume":"17","author":"F Wang","year":"2026","unstructured":"Wang F et al (2026) From multi-target mechanisms to clinical translation: the analgesic potential of quercetin. Front Pharmacol 17:1780749","journal-title":"Front Pharmacol"},{"issue":"20","key":"2364_CR341","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1021\/jm050362n","volume":"49","author":"GL Warren","year":"2006","unstructured":"Warren GL et al (2006) A critical assessment of docking programs and scoring functions. J Med Chem 49(20):5912\u20135931","journal-title":"J Med Chem"},{"key":"2364_CR342","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.3389\/fimmu.2017.01454","volume":"8","author":"AN Weber","year":"2017","unstructured":"Weber AN et al (2017) Bruton\u2019s tyrosine kinase: an emerging key player in innate immunity. Front Immunol 8:1454","journal-title":"Front Immunol"},{"issue":"8","key":"2364_CR343","doi-asserted-by":"crossref","first-page":"697","DOI":"10.36849\/JDD.0824","volume":"23","author":"C Whiting","year":"2024","unstructured":"Whiting C, Azim SA, Friedman A (2024) Applications of Bruton tyrosine kinase inhibitors in dermatology. J Drugs Dermatol 23(8):697\u2013698","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"2364_CR344","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jmb.2009.01.041","volume":"387","author":"NK Williams","year":"2009","unstructured":"Williams NK et al (2009) Dissecting specificity in the Janus kinases: the structures of JAK-specific inhibitors complexed to the JAK1 and JAK2 protein tyrosine kinase domains. J Mol Biol 387(1):219\u2013232","journal-title":"J Mol Biol"},{"issue":"5","key":"2364_CR345","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1365-2125.2011.04150.x","volume":"73","author":"LX Wu","year":"2012","unstructured":"Wu LX et al (2012) Inhibition of the organic anion-transporting polypeptide 1B1 by quercetin: an in vitro and in vivo assessment. Br J Clin Pharmacol 73(5):750\u2013757","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"2364_CR346","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/jdv.18044","volume":"36","author":"J Wu","year":"2022","unstructured":"Wu J et al (2022) Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis. J Eur Acad Dermatol Venereol 36(6):797\u2013806","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2364_CR347","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S420850","author":"M Wu","year":"2023","unstructured":"Wu M, Dai C, Zeng F (2023) Cellular mechanisms of psoriasis pathogenesis: a systemic review. Clin Cosmet Investig Dermatol. https:\/\/doi.org\/10.2147\/CCID.S420850","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2364_CR348","volume":"204","author":"Y Wu","year":"2025","unstructured":"Wu Y et al (2025) Baicalin alleviates intervertebral disc degeneration by inhibiting the p38 MAPK signaling pathway. Exp Gerontol 204:112743","journal-title":"Exp Gerontol"},{"issue":"23","key":"2364_CR349","doi-asserted-by":"crossref","first-page":"7910","DOI":"10.3390\/molecules28237910","volume":"28","author":"M Wujec","year":"2023","unstructured":"Wujec M, Feldo M (2023) Can we improve diosmetin activity? The state-of-the-art and promising research directions. Molecules 28(23):7910","journal-title":"Molecules"},{"issue":"1","key":"2364_CR350","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/13510002.2021.1962094","volume":"26","author":"D Xian","year":"2021","unstructured":"Xian D et al (2021) Current evidence to support the therapeutic potential of flavonoids in oxidative stress-related dermatoses. Redox Rep 26(1):134\u2013146","journal-title":"Redox Rep"},{"issue":"11","key":"2364_CR351","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1002\/cam4.891","volume":"5","author":"Z Xingyu","year":"2016","unstructured":"Xingyu Z et al (2016) Quercetin suppresses lung cancer growth by targeting Aurora B kinase. Cancer Med 5(11):3156\u20133165","journal-title":"Cancer Med"},{"key":"2364_CR352","doi-asserted-by":"publisher","unstructured":"Xu, Z., et al., Catalytic domain crystal structure of protein kinase C-theta (PKCtheta) J Biol Chem. 2004; 279: 50401\u201350409. https:\/\/doi.org\/10.1074\/jbc. M409216200.[Abstract][CrossRef][Google Scholar].","DOI":"10.1074\/jbc"},{"issue":"1","key":"2364_CR353","doi-asserted-by":"publisher","DOI":"10.1038\/srep37977","volume":"6","author":"X Xue","year":"2016","unstructured":"Xue X et al (2016) Pharmacologic modulation of ROR\u03b3t translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis. Sci Rep 6(1):37977","journal-title":"Sci Rep"},{"key":"2364_CR354","doi-asserted-by":"publisher","DOI":"10.1177\/12034754261427395","author":"G Yadav","year":"2026","unstructured":"Yadav G et al (2026) A review of post-inflammatory pigmentation changes: pathophysiology, diagnosis and treatment. J Cutan Med Surg. https:\/\/doi.org\/10.1177\/12034754261427395","journal-title":"J Cutan Med Surg"},{"issue":"6","key":"2364_CR355","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jid.2017.12.028","volume":"138","author":"N Yager","year":"2018","unstructured":"Yager N et al (2018) Expression of PI3K signaling associated with T cells in psoriasis is inhibited by seletalisib, a PI3K\u03b4 inhibitor, and is required for functional activity. J Invest Dermatol 138(6):1435\u20131439","journal-title":"J Invest Dermatol"},{"issue":"1","key":"2364_CR356","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1423-0127-18-84","volume":"18","author":"Y-L Yang","year":"2011","unstructured":"Yang Y-L et al (2011a) Hesperetin-7, 3\u2019-O-dimethylether selectively inhibits phosphodiesterase 4 and effectively suppresses ovalbumin-induced airway hyperresponsiveness with a high therapeutic ratio. J Biomed Sci 18(1):84","journal-title":"J Biomed Sci"},{"issue":"8","key":"2364_CR357","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/ptr.3417","volume":"25","author":"YM Yang","year":"2011","unstructured":"Yang YM et al (2011b) Quercetin inhibits \u03b1-MSH-stimulated melanogenesis in B16F10 melanoma cells. Phytother Res 25(8):1166\u20131173","journal-title":"Phytother Res"},{"issue":"1","key":"2364_CR358","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3390\/ijms21010341","volume":"21","author":"X Yang","year":"2020","unstructured":"Yang X et al (2020) Nobiletin delays aging and enhances stress resistance of Caenorhabditis elegans. Int J Mol Sci 21(1):341","journal-title":"Int J Mol Sci"},{"key":"2364_CR359","volume":"2","author":"Z Yang","year":"2022","unstructured":"Yang Z et al (2022) Classification of JAK1 inhibitors and SAR research by machine learning methods. Artif Intell Life Sci 2:100039","journal-title":"Artif Intell Life Sci"},{"issue":"4","key":"2364_CR360","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/08923973.2023.2166527","volume":"45","author":"Y Yang","year":"2023","unstructured":"Yang Y et al (2023) Luteolin restored Treg\/Th17 balance to ameliorate allergic rhinitis in a mouse model. Immunopharmacol Immunotoxicol 45(4):461\u2013468","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"6","key":"2364_CR361","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/mnfr.201400876","volume":"59","author":"I Yehuda","year":"2015","unstructured":"Yehuda I et al (2015) Glabridin, an isoflavan from licorice root, downregulates iNOS expression and activity under high-glucose stress and inflammation. Mol Nutr Food Res 59(6):1041\u20131052","journal-title":"Mol Nutr Food Res"},{"key":"2364_CR362","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.lfs.2017.04.019","volume":"180","author":"J Yu","year":"2017","unstructured":"Yu J et al (2017) Paeoniflorin suppressed IL-22 via p38 MAPK pathway and exerts anti-psoriatic effect. Life Sci 180:17\u201322","journal-title":"Life Sci"},{"issue":"13","key":"2364_CR363","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.3390\/molecules29133206","volume":"29","author":"MK Zaborowski","year":"2024","unstructured":"Zaborowski MK et al (2024) The role of quercetin as a plant-derived bioactive agent in preventive medicine and treatment in skin disorders. Molecules 29(13):3206","journal-title":"Molecules"},{"key":"2364_CR364","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.694853","volume":"12","author":"R Zain","year":"2021","unstructured":"Zain R, Vihinen M (2021) Structure-function relationships of covalent and non-covalent BTK inhibitors. Front Immunol 12:694853","journal-title":"Front Immunol"},{"issue":"1","key":"2364_CR365","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s11658-022-00355-3","volume":"27","author":"H Zalpoor","year":"2022","unstructured":"Zalpoor H et al (2022) Quercetin as a JAK\u2013STAT inhibitor: a potential role in solid tumors and neurodegenerative diseases. Cell Mol Biol Lett 27(1):60","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"2364_CR366","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/sj.cr.7290257","volume":"15","author":"T Zarubin","year":"2005","unstructured":"Zarubin T, Han J (2005) Activation and signaling of the p38 MAP kinase pathway. Cell Res 15(1):11\u201318","journal-title":"Cell Res"},{"issue":"3","key":"2364_CR367","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1007\/s11030-024-10999-2","volume":"29","author":"X-Z Zhan","year":"2025","unstructured":"Zhan X-Z et al (2025) Modulating JAK2\/STAT3 signaling by quercetin in Qiling Baitouweng Tang: a potential therapeutic approach for diffuse large B-cell lymphoma. Mol Divers 29(3):2407\u20132431","journal-title":"Mol Divers"},{"issue":"2","key":"2364_CR368","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00403-018-1879-8","volume":"311","author":"M Zhang","year":"2019","unstructured":"Zhang M, Zhang X (2019) The role of PI3K\/AKT\/FOXO signaling in psoriasis. Arch Dermatol Res 311(2):83\u201391","journal-title":"Arch Dermatol Res"},{"issue":"23","key":"2364_CR369","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.1039\/D0SC01676D","volume":"11","author":"M Zhang","year":"2020","unstructured":"Zhang M, Jang H, Nussinov R (2020a) PI3K inhibitors: review and new strategies. Chem Sci 11(23):5855\u20135865","journal-title":"Chem Sci"},{"issue":"2","key":"2364_CR370","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1021\/acsmedchemlett.9b00431","volume":"11","author":"H Zhang","year":"2020","unstructured":"Zhang H et al (2020b) Discovery of N-(indazol-3-yl) piperidine-4-carboxylic acids as ROR\u03b3t allosteric inhibitors for autoimmune diseases. ACS Med Chem Lett 11(2):114\u2013119","journal-title":"ACS Med Chem Lett"},{"issue":"34","key":"2364_CR371","doi-asserted-by":"crossref","first-page":"40228","DOI":"10.1021\/acsami.3c07582","volume":"15","author":"Y Zhang","year":"2023","unstructured":"Zhang Y et al (2023) Cyclodextrin-coordinated liposome-in-gel for transcutaneous quercetin delivery for psoriasis treatment. ACS Appl Mater Interfaces 15(34):40228\u201340240","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"2364_CR372","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s40364-024-00711-9","volume":"12","author":"K Zhao","year":"2024","unstructured":"Zhao K et al (2024) The multifaceted roles of cathepsins in immune and inflammatory responses: implications for cancer therapy, autoimmune diseases, and infectious diseases. Biomark Res 12(1):165","journal-title":"Biomark Res"},{"issue":"1","key":"2364_CR373","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/s42003-024-06700-w","volume":"7","author":"T Zheng","year":"2024","unstructured":"Zheng T et al (2024) p38\u03b1 deficiency ameliorates psoriasis development by downregulating STAT3-mediated keratinocyte proliferation and cytokine production. Commun Biol 7(1):999","journal-title":"Commun Biol"},{"issue":"1","key":"2364_CR374","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou X et al (2022) Advances in the pathogenesis of psoriasis: from keratinocyte perspective. Cell Death Dis 13(1):81","journal-title":"Cell Death Dis"},{"key":"2364_CR375","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fmolb.2020.00083","volume":"7","author":"J Zhu","year":"2020","unstructured":"Zhu J et al (2020) Theoretical exploring selective-binding mechanisms of JAK3 by 3D-QSAR, molecular dynamics simulation and free energy calculation. Front Mol Biosci 7:83","journal-title":"Front Mol Biosci"},{"issue":"2","key":"2364_CR376","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s11224-020-01643-4","volume":"32","author":"J Zhu","year":"2021","unstructured":"Zhu J et al (2021) Computational investigation of the selectivity mechanisms of PI3K\u03b4 inhibition with marketed idelalisib: combined molecular dynamics simulation and free energy calculation. Struct Chem 32(2):699\u2013707","journal-title":"Struct Chem"},{"issue":"11","key":"2364_CR377","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/jcc.21816","volume":"32","author":"V Zoete","year":"2011","unstructured":"Zoete V et al (2011) SwissParam: a fast force field generation tool for small organic molecules. J Comput Chem 32(11):2359\u20132368","journal-title":"J Comput Chem"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02364-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02364-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02364-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:55:49Z","timestamp":1792194949000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02364-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":377,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2364"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02364-6","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"7 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"During the preparation of this work, the authors used ChatGPT and Grok to enhance text quality, proofreading, and editing as auxiliaries. After using these tools, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article.","order":1,"name":"Ethics","label":"Declaration of generative AI and AI-assisted technologies in the manuscript preparation process","group":{"name":"EthicsHeading","label":"Declarations"}}]}}